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P R 0 C E E D I N G S 
--ooOoo--
CHAIRMAN SEYMOUR: Ladies and gentlemen, welcome to this 
afternoon's Senate Select Committee on Substance Abuse interim 
hearing, and the subject is, "Drug Testing in California, How Far 
Have We Corne?" 
After five years of extensive involvement in the area of 
drug and alcohol abuse, I find myself in agreement with the many 
experts in the field who say that substance abuse in the 
workplace has become pervasive. Indeed, it is not overkill when 
I say it has reached epidemic proportions. The result has become 
clear: the energy, efficiency and honesty of the American 
workforce is being diluted. 
Unfortunately, while labor and management debate the 
merits of various methods of curtailing workplace substance 
abuse, many innocent citizens and fellow employees are being 
injured and sometimes killed by the accidents or mistakes of an 
employee working under the effects of a mind altering substance. 
I find myself asking more and more how we can explain to 
the families of those victims killed when two Conrail trains 
collided, that this tragedy was not a result of mechanical 
malfunction or human error, but drugs ingested. 
Furthermore, how do we explain to the public that there 
could be a nuclear accident because an employee at the control 
was high on dope? 
Finally, how do we explain to our children the 
27 pervasiveness of drug use by their heroes: the basketball stars, 
28 football players, T.V. and movie stars, even the Olympians. 
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Now, after extensive involvement and lengthy 
deliberation, I am convinced that drug testing in the workplace 
is but one of the steps necessary for solving this nation's 
substance abuse problems. Not only are alcoholism and drug 
addiction deadly human diseases, much the same as tuberculosis, 
cancer, AIDS, and Alzheimer's disease, they are also deadly 
socioeconomic diseases which cost the State of California over 
$18 billion a year. That's over $700 for every man, woman and 
child in this state. 
This high price tag is attributed to employee 
absenteeism, lowered productivity, defective goods, plus 
accidents that result in higher medical and insurance costs. It 
is estimated that over 20 percent of our workforce uses drugs or 
alcohol. 
One of the questions that I am frequently asked when 
talking about substance abuse testing legislation is: why do we 
need law in this area? Why can't we just leave things as they 
are? 
Today, because there is no law setting the parameters 
under which testing will take place, employers and employees are 
flying blind as to their rights. This has led to a proliferation 
of lawsuits, which is causing the courts to write the law in this 
field. Both employees and employers need protection from blatant 
disregard of constitutional rights. Approximately 22 percent of 
California's workforce are represented by labor unions and 
protected by collective bargaining agreements. Without laws 
setting up the parameters under which an employer may conduct 
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drug testing, who is going to protect the other 78 percent of the 
workforce which is not represented by unions? 
Yet another question that is constantly raised is: 
should it take place at all? I'd like to share with you that 
this question has already been resolved. Drug testing in the 
workplace is here to stay, and so I would suggest that the 
question is not "if", but rather "how". 
For these reasons, I introduced legislation in 1986 and 
again in 1987, which would have set up the parameters under which 
an employer could conduct drug testing programs. The two bills I 
introduced in 1987, neither of which mandated testing, were the 
product of discussions with lawyers, doctors, experts on the 
tests, and representatives of both labor and management. 
Senate Bill 1611 would have allowed employers to conduct 
testing on job applicants, and testing of current employees if 
the employer had reasonable suspicion that alcohol or controlled 
substances were present in an employee's body. 
The second bill, Senate Bill 1610, would have allowed an i 
employer to conduct random testing only where the employee was 
employed in a high risk or safety sensitive position and might 
endanger himself or herself, other employees, or the public. 
Both of the bills set forth the parameters under which a 
substance abuse testing program could be conducted by an 
24 employer. The bills contained protections for the employer and 
25 the employees in both the private as well as the public sector. 
26 I believe that these bills represented a realistic approach to 
27 drug testing and struck the appropriate balance between the 
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employer's right to insure for himself or herself, as well as 
their employees, a drug-free work environment, and at the same 
time, protect the employee's constitutional and individual 
rights. 
Unfortunately, both of the bills were killed by the 
Senate Industrial Relations Committee, and in fact, no drug 
testing bill has been passed by the Legislature to date. 
The purpose of this hearing today is to receive input 
from the experts on whether legislation should be reintroduced 
and pursued to once again attempt to set up these parameters for 
drug testing programs in order to protect the employees, the 
I employers, as well as the public. 
We will hear from the legal experts as to how judges in 
California and throughout the nation are ruling on various drug 
testing programs which have been challenged in court. 
We will hear from labor and management on their feelings 
regarding drug testing, and whether there has been any change in 
the opinions of the leaders in these fields since the 
deliberations on our last legislation. 
And finally, we will also have testimony from the 
experts on the tests used for determining whether a person has 
controlled substances in the body, and receive an update on new 
I 
~ 
\!technologies and the current accuracy rates of these tests. 
~ It is my hope that the testimony from these hearings 
)!will tell us how far we have come since we last examined this 
II issue, and how much further we have to go in order to make 
t \\certain that drugs in the workplace become the exception, rather 
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II than the rule, and to accomplish this by ensuring that fair and 
~reasonable guidelines are established. 
~ Our first witness is Mr. Pete Strom, who is Manager of 
I
I .
. ! 
~ the Policy Development Section of the State Department of 
~~jPersonnel Administration. 
~ MR. STROM: Good afternoon. I am Peter Strom from the 
jlcalifornia Department of Personnel Administration. 
j Our Department is charged with implementing Governor 
~ I 
Deukmejian's Executive Order D-58-86, which calls for a drug-free 
State workplace. To help achieve this, we're presently 
establishing a program under which employees serving in sensitive 
positions in State service will be subject to drug and/or alcohol 
testing when there is reasonable suspicion that they are under 
the influence while at work or on standby. 
This will supplement measures already in place to deal 
with employee substance abuse, such as employee assistance and 
discipline programs. 
In my remarks this afternoon, I will discuss our 
approach to the various issues we encountered in developing our 
drug testing policies. 
The State's Executive Branch has approximately 150,000 
employees engaged in a wide variety of occupations, including: 
clerical, administrative, medical, law enforcement, fire 
24 fighting, engineering, maintenance, legal and educational. Our 
25 first task was to decide how widely within this workforce to 
26 apply drug testing. 
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I II There is extensive documentation on drug and alcohol 
!I problems in our society, and we know from employee assistance 
II 
II statistics that these problems exist to a degree within State 
i\ service. While we are committed to dealing with employee 
,, 
6 
I sl·usbastnaenecde abuse problems in all sectors of our workforce, there 
1 
to consider employee constitutional privacy rights 
1
1 
before implementing substance testing as one of the tools in this 
11 
effort. Basically, we felt that we must show where the State's 
I need to test outweighs the employee's normal entitlement to be 
I 
,I protected from such action under search and seizure and privacy 
I 
~provisions. We balance these considerations by focusing our 
1
11 t t · · · · · · h · h · · d f ~\ es 1ng on sens1t1ve pos1t1ons 1n w 1c : 1mpa1re per ormance 
I[ could clearly endanger the health and safety of others; and less 
I 
j intrusive methods could not reliably deal with this problem. 
·11 We are currently in the process of specifically 
\1 identifying these sensitive positions. We anticipate there could 
lbe up to 50,000 of them engaged in such fields as: 1~ 
\!enforcement, corrections, fire fighting, health care, and heavy 
i/ truck and equipment operations, among others. I Next, we considered whether testing in our case should 
I. 
\\be random, periodic, or for cause. Again, there was need to 
I, 
I 
/balance the State's interests with employee rights. Our legal 
!, advice indicated that random is still in some legal dispute, 
\I while there is solid legal support for testing based on 
~reasonable suspicion. I In addition, our review of State agencies indicated that 
[/ the majority of State employees perform their work without being 
1\ 
i' I 
I 
II 
~ 7 
I' 
,I I under the influence of drugs or alcohol. In view of this, we 
i' 
2 I elected to test based on reasonable suspicion. 
1 ~~ With these policy issues decided, we turn to the issues 
4 
5 
6 
7 
9 
10 
II 
12 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
,, 
surrounding the technical accuracy of drug testing. Anyone who 
has spent much time in this area has heard the story about high 
~error rates, questionable sample collection practices, easy ways 
~~~~to beat the tests, improper interpretation of test results. To 
avoid these pitfalls, we included extensive technical safeguards 
I · 1 1 h · /r 1n our ru es. For examp e, t e rules requ1re secure and 
11 professional sample collection methods, formal chain of custody 
~procedures, use of both screening and confirmatory tests before a 
[!sample is considered positive, use of only those labs meeting 
~~either NIDA or College of American Pathologists standards, and 
~medical review of all positive test results. 
:r ~ Finally, there are the issues dealing with employee 
I rights and concerns. In proposing our testing program, we have 
/1 encountered employee apprehension concerning supervisor 
I 
I'[ harassment, test accuracy, invasion of privacy, and due process. 
1
1 
In response to this, we've included the following employee rights 
I 
,I provisions in our rules: employees and unions will be notified 
II and given an opportunity to respond before positions are 
II designated sensitive and therefore become subject to our policy; 
II 
11 before an employee can be sent for a drug test, the initial 
~determination of reasonable suspicion will have to be confirmed 
" ~ by a second supervisor or manager who is specifically trained in 
II I! 
II our testing policy and the detection of reasonable suspicion; 
!' 
1/ employees will have the right to representation in any interviews 
I 
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that could lead to a decision to take action against them; at 
their own expense, employees will have the opportunity to have 
their sample retested at a lab of their choice; employees will 
receive copies of all test results and related documentation; 
confidentiality will be maintained with test results being 
released only on a need-to-know basis; and a licensed physician 
will review all positive results and will consider any medical 
reasons provided by the employees for any positive results that 
may come back on them. 
We are presently meeting and conferring with the 
employee unions concerning these and other aspects of our 
substance testing policy. We will also be providing extensive 
supervisory training during the coming months. 
In addition, we're currently going through the 
competitive bidding process to obtain qualified laboratory and 
sample collection services. 
We expect to bring the program on line beginning in 
February of 1989. 
In conclusion, we have faced a full range of legal, 
technical, and employee relations issues in developing our 
21 substance testing policy. Out of this, we believe we have come 
22 
23 
24 
up with a program that best meets the needs of our particular 
environment and workforce. 
This concludes my presentation. I'd be happy to answer 
~ ~your questions at this time. 
26 CHAIRMAN SEYMOUR: You've been very thorough, Mr. Strom, 
27 and I can see that the State Department of Personnel 
28 
r 9 ! ~ 
I Administration has made tremendous strides. I believe it was 
I 
2 approximately a year ago that you were conducting hearings 
relative to the questions of: would you be testing? If so, 
4 under what conditions? 
5 In reviewing your policies that you have come out with 
6 on behalf of the Governor's Executive Order, it seems to me 
7 you've really moved ahead. 
8 MR. STROM: It's been a lot of work, but I think we 
9 have. 
10 CHAIRMAN SEYMOUR: One question I would have and that 
II is: all these policies, how much of what's included in these 
12 policies is subject to the collective bargaining process? 
13 MR. STROM: The impact these policies would have on 
14 employees would be subject to collective bargaining. 
15 We, at the outset, oh, beginning four or five months 
16 ago, we extended an invitation to all the employee unions to meet 
17 and confer with us over the impact of these rules. And most of 
18 those unions have come in and have been discussing how these 
19 rules would impact their employees. The discussion has gotten 
20 into most of what you see in those rules. 
21 CHAIRMAN SEYMOUR: What is the time table for 
22 implementation? 
23 MR. STROM: Beginning in February of '89, I believe, we 
24 can start bringing the first State agencies or groups of 
25 employees on. We have quite a bit of training work to do, 
26 obviously, and we're still in the competitive bidding process. 
27 
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CHAIRMAN SEYMOUR: I assume you have in place, or will 
have in place, a statistical data collection program showing what 
impact, or lack thereof, may result from such a policy; is that 
correct? 
MR. STROM: We will --
CHAIRMAN SEYMOUR: Accident rates, time off? 
MR. STROM: We gathered -- before we did our rules, we 
visited ten or twelve of the major State agencies that would have 
sensitive positions in great numbers and got some data on their 
experience. We have that, and we will probably go out again and 
see how that was doing after. 
In addition, we're going to be getting data from the 
laboratories that conduct the tests, so we'll know as we go along 
how many tests are being conducted, and how many of those are 
positive. So, we'll be able to track this over time to see how 
we're doing. 
CHAIRMAN SEYMOUR: It is your intention, then, to track 
the performance of the programs? 
MR. STROM: Oh, yes. 
CHAIRMAN SEYMOUR: Thank you very much. 
MR. STROM: You're welcome. Thank you. 
CHAIRMAN SEYMOUR: Our next witness is Duane Morford, 
23 Division Chief, Policy Division, State Personnel Board. 
24 MR. MORFORD: For the record, my name is Duane Morford. 
25 I'm Chief of the Policy Division of the State Personnel Board. 
26 In my testimony this afternoon, I'd like to discuss what 
27 the Board, the State Personnel Board, perceives as its role in 
28 
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·drug testing, and also the steps that we've taken to ensure that 
· drug screening is job-related, and that applicant rights are 
protected. 
With regard to the Board's role, the Board has both 
·constitutional and statutory authority for administering the 
'State's Civil Service Merit Selection System. And this would 
i include determining what tests of fitness are appropriate to 
evaluate applicants for State positions. And since drug-induced 
behavior has the potential, certainly, to seriously impact job 
performance, drug screening may be appropriate for applicants for 
some classifications. And the Board would be, in our opinion, 
the agency responsible for regulating such drug testing. 
In 1986, as the previous speaker mentioned, the Governor 
issued an Executive Order directing the Personnel Board to 
cooperate with the Department 6f Personnel Administration to 
develop policies and procedures to help bring about a drug-free 
State workplace. Since that time, our Board has been considering 
IX the need for and the concerns about applicant drug screening, ar.d 
19 it has had five public hearings on this subject: the first, held 
20 shortly after the Governor's Executive Order was issued, was an 
2l information hearing in December of 1986; that was followed in 
22 April of 1987 by a policy hP.aring, at which policy alternatives 
23 were discussed and considered; then came two hearings on proposed 
24 ~regulations, one in November of '87 and a second one in April of 
25 '88; and the final hearing on this subject was held last month, 
26 and at that hearing the Board did adopt regulations governing 
27 drug screening. 
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Regulations are not yet effective. We're in the process 
of putting together a rule making file right now for submission 
and review by the Office of Administrative Law. We expect the 
earliest date when it might be implemented would be January. 
In adopting the rules, the Board had a couple of 
concerns or reasons. The first was, there are three departments 
that are already screening applicants for peace officer positions 
in State service, and the Board felt strongly that such programs 
and any future programs should be regulated. 
And secondly, it was quite apparent to the Board that 
drug abuse does exist among State applicants. To give you an 
' idea of the significance of the problem, in one recent State 
.: Traffic Officer Cadet Examination, over 200 applicants who were 
interviewed in the selection process admitted to the interviewers 
that they had previously used hard drugs; not any drug, but hard 
·drugs -- drugs the possession of which would constitute a felony 
offense. 
In addition, nearly 50 of these applicants admitted to 
:using marijuana since applying to become State Traffic Officers, 
~ since signaling their intention to be peace officers and uphold 
the laws of the State. 
One of the Departments that's currently screening 
applicants for peace officers is the Department of Corrections. 
They have been doing this for a little over three years. During 
'the first nine months of this year, 71 applicants were 
'disqualified because of positive drug test results, in spite of 
the fact that applicants are told in advance that a drug 
screening test is going to be required. 
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So, the Board felt some regulation in this area was 
necessary. In developing the regulations, the Board attempted to 
craft them in a way that would address some of the major concerns 
about drug testing, such as credibility of test results, the 
confidentiality of test results, and applicant rights and due 
process. 
I want to summarize the salient features of our 
regulations, and in doing so, I hope it will illustrate for you 
the balance we've tried to strike between employer needs and 
applicant rights. 
First of all, the regulations do not mandate drug 
screening of applicants for any classification in State service. 
Rather, they set forward a framework within which a department 
may come forward and request to institute an applicant screening 
program, and they regulate such testing, such tests of fitness. 
The rules only regulate drug screening of applicants at 
initial entry into a sensitive position and do not apply to 
applicants for promotion who are already in a sensitive position, 
and they do not apply to testing of current employees for 
assessing their ability to carry out their jobs safely. That's 
the purview of the Department of Personnel Administration, the 
subject that the previous speaker was dealing with. 
Drug screening of applicants would only be permissible 
under our regulations for jobs where there is a high risk to 
health and safety as a result of drug-induced behavior. Whether 
a job is sensitive would be determined in a hearing before our 
Board, a public hearing, at which a department would need to 
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14 
I' present documentation as to the nature of the duties, the risks 
II 
[! to health and safety, and the sensitivity to drug-induced 
ii behavior. Other parties who are interested would have an 
1\ opportunity to input, and if our Board concurs that drug testing 
li . . f . b 1 d h d . f 1 . ld ~ lS 1n act JO re ate , t en rug screen1ng o app 1cants wou 
11 become a requirement in future examinations for that 
.I 1 · f' · 
11 c ass1 1cat1on. 
II The point is that drug screening of applicants for State 
I' 
.\ 
il positions would not be universal, but would be selective. 
II 
1\ The regulations provide for full disclosure to 
I' 
i\ applicants, both before hand, when they're told when a drug 
II screening test will be required, and afterward, when they're 
11 entitled to know the results of their individual drug test. 
II 
II 
il 
The regulations also set forth standards for the testing 
II laboratories. Only laboratories that are certified by the 
II ~~National Institute on Drug Abuse, or accredited by the College of 
~~American Pathologists and who participate in a quality assurance 
~~~· program may participate in drug testing for the State. 
1 
In order to fail the drug test, a sample must fail two 
li [I separate tests utilizing different methodology. The first, or 
ti 
(\screening test, must use a form of immunoassay tests, the second 
~or confirmatory test uses a technology known as gas 
1\ 
![chromatography/mass spectrometry. Forensic experts in the field 
~have testified before our Board that this represents the "gold 
!I ~standard" in terms of drug testing, drug screening, and is the 
,\ 
~most defensible way to proceed. 
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Regulations also require that a department follow strict 
chain of custody procedures so that samples are not 
misidentified. Applicants are also required to disclose 
medications that they have taken during the two weeks prior to 
the test. This is a protection for applicants against 
inappropriate disqualification based on a positive drug test that 
might result from ingesting a legally obtained and legally used 
substance. 
Applicant appeal rights are specified, as is the right 
of the applicant to have his or her sample retested if they 
choose to do so at their own cost. 
Confidentiality of test results is assured by limited 
access severely to test results and ensuring that the test 
results are used only for the purpose of administering these 
rules; that is, to determine an individual's eligibility to take 
State exams where drug testing is required. 
Finally, the regulations specify the consequences of 
failing a drug test. An individual is obviously disqualified 
from the examination that they're taking. In addition, they're 
prohibited for a period of one year from competing in any other 
State examination for which drug testing is required. I . In addition, if they test positive for a hard drug --
~~aga1n, that's a drug the possession of which would constitute a 
I, 
II felony offense they are prohibited for a period of ten years 
~from competing in any State peace officer examination. I Failing a drug test, of course, would not impact an 
I[ individual's ability to take any other examination for which drug 
~testing has not been deemed job-related. 
II 
II 
1,1 
16 
That concludes my remarks. I'd be happy to try to 
2 
respond to questions. 
CHAIRMAN SEYMOUR: Maybe, Mr. Morford, you can explain 
4 
to me, with all the knowledge you have relative to the testing 
5 
programs on preemployment screening, is what I'm talking about 
MR. MORFORD: Yes. 
6 
7 
CHAIRMAN SEYMOUR: The statistics that you used in your 
8 
testimony, you must understand the pervasiveness of the problem. 
9 
And yet, when I hear what you say, and I read your policy, it 
10 
seems to me you have a more strict policy on existing employees 
II 
than potentially new employees. 
12 
And further, it seems to me that your policy on 
13 
preemployment screening is contradictory to the Governor's 
14 
Executive Order and the stated objectives. 
15 
What I'm saying is, if you have to hold a public hearing 
16 to determine what is a sensitive job, obviously sensitivity, as I 
17 understand your testimony, refers to a high risk type of position : 
18 the employee or the prospective employee might be taking, I'm 
19 reading the general policy of the Department of Personnel 
20 
21 
22 
~Administration. And it says: 
~ "Consistent with 
~ h ~ 
Government Code 
Section 19572 and the Governor's 
23 
i Executive Order D-58-86, no State 
24 employee who is on duty or on 
25 standby for duty shall: 
26 (1) Use, possess, or be under the 
27 influence of illegal or unauthorized 
28 
2 
4 
II 
I, 
'I 
/1 
!I 
I' I 
17 
drugs or other illegal mind-altering 
substances; or 
( 2) Use or be under the influence 
of alcohol to any extent that would 
5 impede the employee's ability to 
perform his or her duties safely 
7 and effectively." 
II 
6 
II 
II 
8 If Now, if all you are going to do is, on preemployment 
It 
9 /1 screening, if all you're going to do is sensitive positions, what I [1 
10 1
rdoes that have to do with the potential employee doing their job 
,/ 
1/ effectively? 
jl In a word, you've got a tougher policy on existing 
,I 
II 
12 
13 !!employees than you do on prospective employees. And you set 
14 \!yourself up, in my opinion, therefore, for the problem, because 
JJyou are hiring the problem rather than screening the problem. 
II 15 
16 (/once it's in your system, you know better than I how tough it is 
II 
17 
IX 
19 
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24 
25 
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II to get it out. 
~ MR. MORFORD: You've raised several points. I'll try to 
~respond to as many as I can recall. 
li 
II 
First of all, our regulations do not deal with current 
!employees. That's the Department of Personnel Administration's 
I . 
,
1 
purv1ew. 
/ Our responsibility is limited to applicant testing. 
~That's what these regulations relate to. 
I The only current employees who would be tested would be 
)/those in a nonsensitive position who apply to be appointed to a 
'I ~sensitive position. 
I 
II 
I! i 
II 
They would be subject to testing. 
2 
4 
s 
6 
7 
8 
9 
10 
II 
12 
14 
IS 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
I' il 
18 
~ With regard to the definition of "sensitive," we have 
1: 
1\ coordinated with, very closely, with the Department of Personnel 
II d · · · d · 1 h d f · · · [1 A m1n1strat1on, an we are us1ng exact y t e same e 1n1t1on of 
~"sensitive" as they are. There is no difference. 
ll With regard to the need to hold the hearings to 
:1 
II determine which classifications are sensitive, one of the 
II 
11 concerns that was raised early on when we were considering 
,I 
II proceeding with a drug screening program was, obviously, the 
il 
I[ legal issue and the potential of being sued. In fact, we've been 
II 
\
1 
assured by some unions that we will be sued as soon as we 
I 
i implement the program. 
~ And so, the legal advice we received was that you need 
II to carefully lay a record that shows that you're not just 
II arbitrarily and capriciously identifying a position as sensitive, 
II 
1) and therefore, as one for which drug testing is job-related. You 
\1 need to have the departments come in and lay out evidence that I proves that point so that if you're later sued, you go into 
II ~court, you've got a good, sound basis for defending your program. 
II ~That's why we decided to proceed with it in that way. 
!) 
~ Despite that fact, you know, we're not going to delay on 
li 
1\ implementation. I indicated in my testimony that we expected the 
[\rules to become effective in January of 1989, and that's assuming 
II 
ilthe Office of Administrative Law approves them. We're also ~planning to schedule the very first hearings in January, 1989, of 
~those departments that are most interested in having drug 
liscreening programs approved. So, we're proceeding quickly. 
II I 
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CHAIRMAN SEYMOUR: Can you recite any court case that 
found constitutional right problems with preemployment screening? 
MR. MORFORD: I'm not familiar with any, no. 
CHAIRMAN SEYMOUR: Neither am I. 
I'm shocked, quite frankly, that the Personnel Board 
would adopt a posture that seems to say, "We'll inherit the 
problem, and once we've got it, then we'll implement testing 
programs that might straighten it out, or help to straighten it 
out." 
In a word, how come you're not preemployment --many 
firms, many of the nation's Fortune-500 companies, at a minimum 
have a preemployment screening program for every employee. 
That's the easy way. The tough one is reasonable suspicion, and 
tougher yet is random. 
I'm shocked! 
MR. MORFORD: Well, the advice we received from our 
legal counsel when we embarked on this endeavor was that, you 
know, the courts haven't said the final word; although there may 
not be 
CHAIRMAN SEYMOUR: Not on preemployment. 
MR. MORFORD: Although there may not be any court cases 
22 that I'm aware of on preemployment screening, it is possible that 
23 they will come forward. In fact, as I said, we've been assured 
24 we're going to be sued. And we want our program to survive that 
25 
26 
27 
28 
lawsuit. 
CHAIR}1AN SEYMOUR: Well, I'm quite confident, and 
there's probably the talent in this room that can tell you how to 
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II devise a preemployment -- and again, I want to emphasize pre-
1\ employment -- screening program that is constitutionally sound. 
~ 1 II Again I'll say, and then I'll get off it, I just find it 
~ 
l\ totally inconsistent with what the Governor's Executive Order 
~ 
~says: "work effectively in an environment." Yes, he talks about 
~a high safety risk, but he says, "work effectively." 
t Now, if I'm stoned, and I happen to be a clerk, how do I ~ ~work effectively? Or if I'm a Caltrans engineer, designing 
t 
\!highways, how do I work effectively? You can go on and on. 
~ ~ I've said my piece. Thank you very much. 
Colonel John Wallace, Special Counsel to the Assistant ~ 
\!Attorney General, United States Department of Justice. 
I I l 
COL. WALLACE: Thank you, Mr. Chairman. 
First, on behalf of Attorney General Dick Thornburgh and 
ilthe United States Department of Justice, we thank the Chair for 
~inviting us to participate today. 
~ 
I It's my intention to give you a little insight into the 
\1 federal experience with workplace drug testing, and the strengths 
II and weaknesses and warps, and where we're having difficulties, 
~ 
II and where we think we're really making some strides. 
~ 
~ 
~ ~ 
CHAIRMAN SEYMOUR: Thank you. 
COL. WALLACE: First, sir, I'd like to clear up a little , 
\!confusion about that title that you just used. I am Special 
' [!Counsel to the Assistant Attorney General of the United States. 
I ~Coincidentally, I happen to be a military officer on detail to 
~the Justice Department. But I am appearing before you, sir, as 
! ~ ~an officer of the Justice Department, not as a member of the ~ 
I ~ 
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II I United States military. So, the testimony that you're about to 
II hear is Justice Department testimony, not that of any military 
11 department. 
[) CHAIRMAN SEYMOUR: Very good, thank you. 
I) COL. WALLACE: Sir, in the course of my testimony today, 
I[ I'm going to make reference to several documents. Now, I have 
li brought several copies of those documents with me, thinking that 
II the Committee might find those documents helpful. Unfortunately, 
the last that either I or United Airlines saw those documents was 
at Dulles Airport this morning around 4:00 A.M. I have assured 
II your staff, sir, that any documentations that I refer to in the 
~course of my testimony, to include a compendium of all -- a 
I summary of all the federal cases on drug testing, current as of 
11 about noon yesterday, I'll be happy to provide to the Committee, 
~~and as many copies as the Committee desires. 
~~ CHAIRMAN SEYMOUR: Thank you, sir. 
,, 
II COL. WALLACE: Sir , I can' t expound -- it would be 
I) presumptuous of me to do anything with respect to the eloquent 
)1 opening remarks of the Chair with regard to the impact of drugs 
II on our community. But just to put my testimony in context, let 
~me certainly endorse your remarks. 
~ It is our feeling that the United States and its 
!citizens face no greater threat from any foreign power than the 
lthreat we currently face from drugs. 
~ Over the last few years, the nature of these substances 
II has changed dramatically. Their availability has skyrocketed 
27 astronomically. Despite the valiant efforts of our law 
28 
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22 
il enforcers, the price of cocaine on the street continues to drop; 
II 
~it has dropped more than 50 percent in the last three years. 
~ 
\I It's a supply-driven economy, sir. That simply means that in 
\1 spite of all of our efforts, the supply on the street has gone 
~up, causing that price to go down. 
~ 
ii 
il There's a greater potency and greater likelihood of 
,I 
[\addiction with these substances. One in ten casual users of 
II 
iicocaine will become addicted. By the time the sun sets on the 
II State of California this evening, 5,000 more Americans will have 
~~~tried cocaine in the United States today for the first time. 
f There's a greater lethality. Look at the tragic loss of 
~~Len Bias; look at the tragic loss we're having in some of our 
·other communities. Look at the appalling incidence of violent 
lcrime associated directly with drug abuse. The District of 
ilcolumbia, our nation's capital, this morning suffered its 288th 
!!homicide in calendar year 1988. In excess of 90 percent of those 
~homicides were drug-related; in excess of ~o-thirds of them 
!i involved youths between the ages of 17 and 25. There can be no 
~greater tragedy than the loss of our youth. 
~ ~ The revenues associated with illegal drugs over the last 
lyear ~ou~t~d to some $110 billion. With that kind of money on 
~the barga1n1ng table, the traffickers are much more willing to 
' r litake greater risks; they're much more willing to allow four 
II shipments to be interdicted to get the fifth one in; they're more 
~ 
I! sophisticated. Frequently they're out-resourced. By that I 
lmean, they're better equipped and better capable to engage in 
conduct than we are to interdict them. 
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There are 120,000 in New York City today who are HIV 
positive. They are HIV positive not as a result of the activity 
of the gay community, but as a result of addiction to intravenous 
drug addiction. We have ward and ward after ward of newborn 
infants who are not only addicted to crack and also methadone, 
but those infants are also HIV positive. They have a prognosis 
of zero. None of them will see their third birthday. 
To date, sir, our efforts in the United States have 
focused almost exclusively on the supply effect side of the 
equation. Somehow, we've got to come up with a rational attack 
I on the demand or cause side of the equation. 
I And we've started that. We've got comprehensive 
!/education programs and comprehensive rehabilitation programs. 
iaut the insurance policy that backs those two programs up, that 
~puts an honesty test on the whole system, we feel, is drug 
[[testing. And that's why the President and the Executive Branch 
~is so strongly in support of drug testing. 
~ i You know, you mentioned in your opening remarks, sir, 
Do you know that since that accident, ~the tragic Amtrak crash. 
11there have been 41 other incidents involving railroads in the 
~ ~United States where at least one member of the crew tested 
~~positive for some controlled substance. In those 41 accidents 
land I'm not here to tell you, sir, that those 41 accidents were 
~caused by drug use, but the fact remains that there were 41 
/!incidents where crew members tested positive -- 29 people lost 
~ 
litheir lives; 341 people were injured; and the total cost of the 
'damage was in excess of $28 million. That's a terrible cost 
~we're paying. 
~ 
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The object of drug testing is to modify human behavior. 
It's the deterrent effect. Quite frankly, we couldn't care less 
about catching someone. That is secondary. Primary is the 
modification of the behavior. 
Drug testing has got a proven track record. You know, 
in 1981, we had the tragic crash of the F-14 on a deck of the 
Nimitz aircraft carrier. And while the flight crew of that 
aircraft was clean with respect to illegal drugs, when they 
tested the deck crew, they determined that an extremely large 
portion of that deck crew had in their systems at the time of the 
accident some form of controlled substance. 
So in 1981, the military began a comprehensive screening 
of uniformed members of the armed forces on a random basis. At 
that time, as much as 50 percent of the tested population in the 
age group 17-25 tested positive for marijuana, cocaine, opiates, 
barbiturates, and amphetamines. 
The latest figures released by the Defense Department 
show that same population has reduced the incidence of positives 
to beneath three percent. There is no other program we've got 
where you can demonstrate a behavior modification that approaches 
that. 
Building on the experience of the NFL, experience of 
several of the Fortune-500 companies, and the experience of the 
military, on September 15th, 1986, the President signed Executive , 
Order Number 12564. For the first time, he established a federal i 
workplace -- a drug-free federal workplace as a national goal. 
Each agency was required to develop and implement a plan designed 
to achieve that goal. 
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Among the elements of the plan were mandatory random 
testing of employees in what is called testing designated 
positions. What the previous witnesses, I assume, would refer to 
as sensitive positions. These were defined in the Executive 
Order as employees whose job performance directly related to the 
public health and safety, the national security, the government 
integrity, or other sensitive consideration. 
Also required to be tested on a random basis were 
volunteers. Now you say, well, why in the world would anyone 
,!volunteer for something like this? When we announced the policy, 
jlwhen we announced the employee assistance program, and we offered 
11 assistance to employees, you'd be surprised the number of 
,i1 employees who have come forward voluntarily and said, "Yeah, 
~throw my name in that hat." Why? It may be they wish to prove 
~to a supervisor that they're in fact clean, or it may be that 
jl they need that little extra encouragement to stay clean. For 
I whatever reason, we're seeing an unusually high incidence of 
~ !volunteers. 
I 
~ 
In addition, the agencies were also permitted to 
11 implement drug testing on a discretionary basis of all 
I 
J/ applicants, all individuals involved in an accident or other 
! 
ilunsafe practice, and all individuals displaying reasonable 
~ ~suspicion of illegal drug use. 
~ In addition, the agencies were directed to establish 
!employee assistance programs and comprehensive education 
/(programs, and were permitted within the discretion of the agency 
jhead to establish a safe harbor program. Most of the agencies 
j 
f j ~ ~ 
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II 
II have established safe harbor programs. Under this program, sir, 
I, ~an employee can come forward on his own volition and say, "Look, 
1\ 
~I've got a problem," with a guarantee that no retaliatory or 
'I q 
I! reprisal disciplinary action will be taken against him, so long 
il as he successfully complete a rehabilitation program and 
I I thereafter refrains from the use of illegal drugs. 
I 
il The last and principle point I want to make about the 
,, Execut1ve Order, sir, is that it prohibits the use of drug test 
II ~~results in any criminal prosecution. This is the touchstone of 
~~the Executive Order in the federal program. We're engaging in 
~~this drug testing not as law enforcers, but as employers. And 
1\ that's where we buttress our legal arguments when we face a court 
IJ 
!I challenge. That while an employee does not give up his 
II constitutional rights just because he works for the federal 
11 government, the corollary of that argument is: just because the 
~employer happens to be the federal government, doesn't mean the 
li 
'I ~employer forfeits all of his or her rights, either. 
\1 The Executive Order, in stating that the results may not 
II 
!lbe used in criminal prosecution, specifically directs agency 
I, 
1heads to respect the dignity, privacy, and confidentiality 
j, 
11 interests of the individual employee to the maximum extent 
II ~permitted to achieve this federal goal. 
I \ Now, after promulgation of the Executive Order, the 
!\congress, in Section 503 of the Supplemental Appropriations Act 
II 
lof 1987, est~lished a hierarchy of federal agencies: Tier I 
~~being the major Cabinet agencies; Tier II being those agencies 
!who had already been involved in drug testing, and several of the 
II 
I' 
,I 
ll 
I' 
,I 
2 
5 
6 
7 
9 
10 
II 
12 
13 
14 
15 
16 
17 
19 
21 
22 
23 
24 
25 
26 
27 
28 
27 
law enforcement agencies, for example, Mr. Chairman, have been 
doing random testing for years; and Tier III were the smaller, 
semiautonomous federal agencies, such as the Tennessee Valley 
Authority and others. 
With respect to Tier I, the Congress directed that the 
~~Secretary of Health and Human Services certify all of those plans 
II simultaneously to the Congress. The objective that Congress was 
/i attempting to achieve by this requirement, sir, was to achieve 
[I uniformity of treatment of federal employees across the board. 
~As it turns out, it was a good idea. In April of '87, the 
~Secretary of HHS in fact did certify 42 Tier I plans to the 
r ~~Congress, and that certification was a prerequisite to any drug 
~testing in any of those agencies. So that now we have about 95 
II percent of the federal workforce playing by the same rules. 
~ In addition, Section 503 required the Secretary of HHS 
II to promulgate specific mandatory guidelines to ensure quality 
!1 control, privacy, and confidentiality of the federal drug testing 
r )!program. These guidelines were first published in February of 
1! 1987, and were finally published in April of '88. They 
1
1
1 proscribed stringent standards for laboratory certification and 
:!quality control, testing protocols, specimen collection and chain 
~ ~of custody procedures, and specific privacy and confidentiality 
j 
~rights of employees. 
~ d For example, under the federal program, testing is ~ 
11 limited to marijuana, amphetamines, opiates, cocaine, and 
liphencyclidines, and no other substance. That becomes important 
![when we begin to discuss the cases, sir, because one of the 
~ ~ ~ 
~ ~ 
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I attacks is that a urinalysis subjects the employee to kind of a 
11 
\[window-on-the-world intrusion. And in fact, there have been 
~ instances in the United States where government entities have 
II used urinalysis for illicit purposes to determine, for example, 
II 
11 the existence of diabetes, the existence of pregnancy, or other 
[I physical characteristics that, quite frankly, the agency's simply 
~~ got no business knowing. 
,, 
~ In addition, the federal standards require that all 
~~positive results out of the laboratory first be reviewed by a 
1
\medical review officer before management is notified of the 
,, 
:I 
/1 result. That medical review officer must be a physician who is 
'j'i specifically trained in substance abuse. In addition, the MRO 
must afford the employee an opportunity to explain away a 
I 
I positive result before that result is reported to management. 
~ Some of those substances I just ticked off, for example, 
llamphetamine and cocaine, while very limited in use, still have 
11 legitimate medical uses in the United States today, Mr. Chairman. 
~~And if the employee can explain it away, more power to him. 
1 Furthermore, with some of the nondiscrete opiate 
I 
1
1 
consumptions -- for example, large quantities of poppy seeds 
:i 
:1 can cause an individual, within 24 hours, to produce what would 
,I otherwise be a positive for opiates. Now, I'm not talking 
~heroin, sir; I'm talking of generic opiates. 
II 
II 
Now let's talk, with your permission, for just a sir, 
[I 
1\moment about the federal drug testing program in practice, first 
!with respect to the collection procedures. 
II 
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I 
[I 
The collection procedures are spelled out in some great 
1
1 detail in a collection manual designed to preserve the dignity 
,) 
[I and privacy of the employee without defeating the drug testing 
II ~program. Laboratory procedures and protocols include: an 
;i 
II initial immunoassay screen, followed up by a GCMS confirmatory 
II 
11 test, that gas chromatography/mass spectrometry test. In 
I addition, on a daily basis, all of our labs are subjected to both ' 
l[ negative and positive blind controls for quality assurance with 
II very narrow bands of tolerance. That is, for example, a known 
positive of a known potency would be sent to the lab, packaged as 
if it were an ordinary specimen. The lab must report a result 
within a very narrow band of tolerance in order to maintain its 
certification. 
I There is a requirement that all positive specimens be 
)1 maintained for one year under carefully controlled environmental 
,/ 
11 conditions. In the event the medical review officer directs a 
I retest, that specimen must be maintained for a retest. 
' Now, in terms of the MRO procedures, that is the medical 1 
11 review officer, he is required to be knowledgeable of the labs he 
[[is dealing with, review the laboratory report, conduct an 
il individual interview with the employee. He can direct, as I 
II . d' d t f t . d . A d h t b ~ 1n 1cate , a retes o a re a1ne spec1men. n e mus e 
!
1 
satisfied, in his own mind, medically and scientifically, that 
I, 
I that is a valid laboratory analysis of this employee's urine 
!before he reports that result to management. And only those 
)ltests that pass the MRO's muster are ever reported to management. 
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'i In the event that the MRO is unsatisfied with the result 
I he receives, he simply reports a negative to management, and then 
!I 
If reports the difficulty to the National Institute of Drug Abuse so 
\\we can conduct whatever corrective investigation is necessary 
~with respect to the lab involved. 
Now, what are the management responses to a positive 
11 test? In other words, what happens to an employee who tests 
II positive? 
I! 
Well first, the employee is administratively removed 
II 
!j from that sensitive position until he completes some sort of 
II rehabilitation. If he's a heavy equipment operator, and we've 
11 got a positive test result, we've got to remove him from the I operation of heavy equipment pending some sort of reinstatement. 
1 Furthermore, if he's got a security clearance, the 
II security clearance is suspended until such time as he 
11 successfully completes rehabilitation. The employee is then 
~~offered assistance through this mandatory employee assistance 
I, 
li program. 
II 
~ Disciplinary action must be initiated but not 
11 necessarily consummated. Now, that's different from the removal. 
I 
liThe removal was a matter of public safety. The disciplinary 
\!action must be initiated, but the agency head, on a showing of 
/1 sincere effort on the part of the employee, if the agency head 
II 
,, 
~desires, may hold that disciplinary action in abeyance. He need 
l
lnot carry it through to fruition, with one exception. There is a 
1 
mandatory removal from federal service of all repeat offenders 
!I 
II 
l
'iand all employees who refuse, having been tested positive, to 
cooperate with the employee assistance program. 
I 
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Let's talk for a moment about --
CHAIRMAN SEYMOUR: On that last point. 
COL. WALLACE: Yes, sir. I'm shotgunning you, so please 
interrupt. 
CHAIRMAN SEYMOUR: That last point. If I test positive 
once, then I come under that condition? Either I cooperate with 
the employee assistance program, or I'm gone? 
COL. WALLACE: Yes, sir. 
And part of that employee assistance program, by the 
way, involves periodic retests to ensure that you're staying 
clean. 
If I can, sir, I'd like to kind of talk about drug 
1 testing litigation generically. We've got right now on hand 
I 
1 about 25 cases, and they range from cases that will be argued 
before the Supreme Court on November 2nd, to cases in about 15 
different districts of the Federal District Courts. 
But generically, drug testing is becoming more and more 
1 prevalent, both in the private and public sector. Many, as you 
!mentioned, Mr. Chai~an, many of the Fortune-SOD test. 
~ I might also tell you that approximately half of all the 
/commercial companies in the United States conduct some form of 
1jdrug testing or another, to include Rolling Stone magazine, who 
1: subjects its employees to both applicant and random testing, sir. 
u 
~Many States, municipalities, and semiautonomous government 
~corporations also conduct tests. Transportation districts, 
!!utilities, all manner of law enforcement, fire, and paramedic 
junits conduct testing. 
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However, despite the procedural safeguards and advancing 
laboratory technology that I've tried to describe in the 
preceding few minutes, sir, drug testing is by no means 
universally accepted. 
I must point out, Mr. Chairman, that each case turns on 
its individual facts, but we can make some general observations. 
In general, drug testing has been widely upheld in the Federal 
District Courts in all circuits except the 9th Circuit, that is 
the circuit here in California, and the District of Columbia 
Circuit, which are now, of course, the most popular circuits for 
the plaintiffs to bring their actions against the federal drug 
testing program. 
Generally, the earlier cases were brought by individuals 
who had already tested positive and who were now, ex post facto, 
contesting the legitimacy of the test. Perhaps, for lack of 
emotional appeal on the part of the plaintiff, we were almost 
universally successful in defending those cases. 
The more recent cases, however, have been brought by 
either groups of employees, such as 41 attorneys in the United 
States Justice Department, or by labor organizations seeking to 
q enjoin further implementation of the President's Executive Order 
II 
~and the agency drug testing plan. 
II 
~ Now, the position of the government in these cases can 
1: 
I! be summarized like this, sir: 
li 
II Point one, the government is engaged in drug testing in 
11 
li its capacity as employer, not law enforcer; therefore, the 
II 
ii traditional Fourth and Fifth Amendment criminal law standards are 
II I. ,, 
jl 
:I 
II 
II 
i' 
II 
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~ 
/I inapplicable. To be sure, we're still bound by the Fourth and 
II Fifth Amendments, but the rules take on a different context where 
h 
II' we're engaged in activities as an employer and not as law 
I enforcer, and where the criminal sanction is expressly prohibited 
j by the Executive Order. 
I
I Number two, the government need not wait for a disaster 
I to occur before it takes reasonable preventive measures. we 
I don't have to have the first one of our FAA air traffic 
jl controllers turn to cocaine in response to stress and let a 747 
il go down before we affirmatively get in there. And remember, I about two-thirds of this program is geared toward helping the 
1 employee. It's not Orwell's 1984. 
Third, the government has a compelling interest in 
ensuring that its workplace remains drug-free, at least with 
respect to employees whose performance affects public health and 
safety, law enforcement, the national security, or who are 
otherwise potential targets for graft, corruption, blackmail, or 
extortion. 
And finally, the drug testing program being implemented 
by the government is a reasonable, limited intrusion, which 
respects the dignity and privacy rights of the individual being 
tested. 
Now, we haven't been able to sell those points 
universally, sir. 
The points of those, the plaintiffs, who are currently 
involved in litigation with us can be summarized, and I'm not 
speaking for them, but I think this is a fair analysis of their 
argument: 
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First, drug testing is an unreasonable intrusion into 
the individual's private affairs. 
Second, drug testing has a large potential for abuse. 
34 
The government can use it as a subterfuge to intrude into areas 
of an individual's personal life other than illegal drug use, 
such as pregnancy or disease, or other individual physical 
attributes. 
Third, drug testing will not measure on the job 
impairment, and as such, represents an unreasonable intrusion in 
the individual's off-duty conduct. 
That argument, sir, in drug testing we're looking for 
metabolites. The metabolites are the residue from a chemical 
substance after that substance has been metabolized in the body. 
So that if you looked at a curve of impairment and a curve of the 
presence of metabolites in the urine, you would find a delay 
between impairment and the presence of metabolites and where they 
peak. And of course, our drug testing in fact does measure the 
presence of metabolites, and so the argument is: I was impaired 
in my off-duty hours, and I've just got metabolites on the job. 
And that's a valid argument, and we counter that 
argument with the argument that we're looking for: number one, 
the judgment factor involved in the employee; and number two, the 
nexus with some of these substances between use of that substance 
and complete system failure is so high that the presence of those 
metabolites is sufficient to trigger a compelling government 
interest. 
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And finally, the plaintiffs would argue that the 
government has failed to establish that any problem of drug abuse 
by federal employees currently exists upon which drug testing can 
be predicated. In other words, in the case involving the 41 
lawyers of the Justice Department who sought to enjoin our drug 
testing program within DOJ, sir, and we are currently under an 
injunction, argued that there was there had never been any 
evidence of drug abuse by Justice employees. 
We have countered that with some specific case examples 
where we have had drug abuse. 
Sir, with $110 billion of revenues in illegal drug trade 
in this country on an annual basis, that's enough money to turn 
anybody's head. So that's our response to that argument. 
Now, I'll be happy to provide your staff, sir--
unfortunately, I would have had it with me today but for the 
assistance I got from the airline -- with a complete compendium 
.,of all federal litigation involving drug testing, current as of 
ij 
And this is a summary of every case which we ijnoon yesterday. 
~have been involved in from the beginning. 
I 
I might cite to you, sir, five cases that are of some 
!significance and interest, I believe, to this Committee. Two 
Jwill be argued before the Supreme Court on November 2nd. There, 
~ 
/lthe Railway Labor Executives Association vs. Burnley, this is a 
~ ~post-accident test. Governor Dick Thornburgh [sic] will 
lfrepresent the United States in arguing that case before the 
~Supreme Court. And the National Treasury Employees Union vs. 
~ ~Von Robb, this is an applicant screening. These were in-service 
I applicants for the Customs Service, sir. 
I 
\ 
\ ~ 
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li 
\! Quite frankly, we're very confident with respect to both 
,I 
II 
!I 
1 of those cases because, as you pointed out in your early 
I ~questioning, those are two of the easier forms of testing to 
I 
II defend. Although, between you and me, sir, our position would 
II 
11 be: if we had to choose one, the one we want is random. 
,[ 
[i The other two cases are the National Federation of 
II 
11 Federal Employees vs. Carlucci, and the American Fed.eration of 
It 
![ Government Employees vs. Burnley. Very summarized, sir, NFFE vs. 
\)Carlucci involves the Department of the Army's drug testing 
It !I program. Among the employees we were testing there were civilian 
il guards of nerve gas agents at a storage facility in Alabama that 
liwe felt we wanted to have a firm handle on, and air traffic 
il controllers in the FAA. 
,, 
II il Those cases were both argued in front of the Circuit 
I! [\Court of Appeals, the D.C. Circuit, on October 18th, and we 
II anticipate that by mid-November, we'll have a decision out of the 
\, 
ijcourt on those two cases. 
f, 
~ Based on the questions that the judges put to 
I. 
!!plaintiff's counsel, we walked away feeling fairly comfortable 
)\that the judges at least understood our position and why, where 
)) public safety is so much at stake, the government's interest is 
II ,, 
~so compelling that when you balance the dignified intrusion into 
II 
11 this limited area of personal privacy, that the government's 
L 
~interest prevails. I Sir, the final case that I've already mentioned is a 
I' ~case called, Harmon vs. Meese, in which the Department of Justice 
.I ~was enjoined from implementing its own random drug testing 
li II 
II program. 
II 
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It's only our random program, by the way, sir, that's 
been enjoined. We're proceeding with applicant, post-accident, 
reasonable suspicion testing and follow-up testing. Only the 
random testing has been enjoined. 
That case has been docketed in front of the D.C. Circuit 
Court of Appeals for later in November, and I'll be happy to pass 
on the results of that case when it becomes available. 
The current position of the Department of Justice with 
respect to our client agencies is: continue to implement the 
drug testing programs; if the drug testing plan of your agency 
includes random testing, and it surely shall because it's 
mandated by the Executive Order, continue to implement that 
program; don't do anything foolish, if you're enjoined, abide by 
the order of the court. 
But, we're not hanging crepe and wringing our hands 
simply because we're in litigation, sir. 
One other thing I might throw out, sir, because it's 
I 
11 rather timely. You know, the Congress was debating the omnibus 
1
1Anti-drug Abuse Act late last week. There were some interesting 
11 things in the Senate and House versions of that bill. First, on 
/the Senate side, there were requirements for drug testing among 
I 
liNuclear Regulatory Commission agency employees. There was also 
~ I some requirement that some Transportation agency employees and 
,!contractors conduct random drug testing. That all fell out of 
~the bill at the 11th hour. I More interesting to this Committee, however, was a 
'provision from the House side of that bill that would have taken 
~ j I 
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II those mandatory HHS quality control guidelines for labs and would 
II 
11 have applied those across the board, not only in the other, the 
/I 
:I 
!I rest of the public sector -- that is for municipalities and the 
~States -- but also for the private sector. In other words, 
II 
lj before any employer could engage in drug testing, he would have 
il 
11 to use the services of a HHS-certified laboratory. That 
II 
li 
II provision also fell out of that bill late Thursday night, sir, 
~and when the final bill passed, it was not included. However, 
" . 
11 prom1ses were exchanged between the two bodies that they would 
d 
II revisit the issue early on in the lOlst Congress. 
i! 
I 
1! The other interesting aspect of that bill as passed is, II 
1! 
it authorized four States on a trial basis to conduct applicant 
screen testing for State automobile operators' licenses. And we, 
of course, have not seen any rules and regulations with respect 
to how we're going to implement that statute, but that's out 
there on the horizon. 
Sir, that's kind of the waterfront, and I know I've 
asked you to drink from a fire hose here in the last few minutes. 
I'll be happy to entertain any questions you might have. 
CHAIRMAN SEYMOUR: Let me say, Colonel Wallace, I thank 
21 you for taking the time to come here to California and be with 
22 us. 
23 I am really amazed. I follow very closely this whole 
24 issue, of course, and I followed closely when the President 
25 issued his Executive Order. And I thought to myself at the time, 
26 quite cynically: ha, ha; sure. I'm amazed at the progress that 
n you have made. 
28 
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II ~~me, 
i/ I, 
I don't know whether you can answer this question for 
but even a guess would give me what I'm looking for. 
Out of all federal employees, and I have no idea how 
39 
I I many they number, setting aside the military, out of all other 
I 
federal employees, how many positions have preemployment 
I 
screening? Any idea? 
Sir, it would be the overwhelming II . . COL 0 WALLACE: 
I[ maJOrl ty. 
II CHAIRMAN SEYMOUR: 
I' 
Is that right. 
COL. WALLACE: Now, I say the overwhelming majority. It 
has just been in the last 60 days that the collection contract 
for these mass collections has been let and the contracts for the 
labs have been let. So, it's still in the infancy stage, but at 
least pursuant to the agency rules, the overwhelming majority of 
federal applicants will be asked to undergo urine analysis as 
I part of the federal employment application. 
I' i[ CHAIRMAN SEYMOUR: You had indicated, Colonel Wallace, 
i[as you go through this litigation, that if you had your druthers, 
/!you feel that random would be the one you'd opt for, if that was 
I the only tool you had in your kit. 
li COL. WALLACE: Yes 1 sir. 
il 
I.', CHAIRMAN SEYMOUR: Could you expound on that? Is it 
'because-- well, I'll let you answer the question. 
I I, COL. WALLACE: Sir, it's our view that random testing is 
If really the only one where you've got your existing workforce and 
tlyou're in a proactive mode. You're not trying to close the barn 
~door after the cow has walked out. 
'I I I, 
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It's also the one where, even if we only test 10 percent [I 
:I 
\[of the population, the impact is going to be felt on 100 percent 
/i of the population. 
I' II 
II You know, I've been subjected myself, personally, to 
[I random drug testing now for about 10 years. And I've got to tell 
,I 
II you that for about the first six years, my feelings were kind of 
li hurt because my number never came up. And within the 90 days 
l1 
~~after that thought crossed my mind, I think I got an opportunity 
;I to participate four times. So, it is genuinely random. 
li 
I' 
That has an impact. You know, this is my personal 
opinion, we're not after putting people in jail. That's why the 
President said there will be no criminal prosecution. 
The object is to keep the workplace clean so that we 
don't have any disciplinary action, so that we don't have any 
removal actions. And if that -- and I sound like a salesman for 
drug testing, and I don't mean to but if that's the way to get 
there, then that's the insurance, dishonesty insurance, that 
underlies the education and rehabilitation programs that attack 
the demand side of the equation. 
CHAIRMAN SEYMOUR: Do you have in place tracking systems 
21 so that you can compile data as to where you've been and where 
22 you've gotten to? 
COL. WALLACE: Yes, sir, we do. The National Drug 
24 Policy Board, which is a Cabinet level entity, has exhaustive 
25 precedence files, if you will. I attend meetings on almost a 
26 daily basis over at the Executive Office Building. There's a 
27 great deal of frustration by Dr. Ian MacDonald, who's the 
2R Director of that entity, that we're not moving fast enough. 
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But yes, we've got exhaustive lessons learned, and there 
are some that I'd be happy to share if you wanted, where we 
thought: boy, I wish I had that one to do over again. There's 
been a pretty steep learning curve on this, sir. 
CHAIRMAN SEYMOUR: What I'd be interested in is with the 
u.s. Post Office. I recall reading a couple of years ago, maybe 
three years ago, where a preemployment test took place on U.S. 
Postal potential hirees. And some extraordinary number -- I 
don't know whether it was 30 percent, 40 percent, but somewhere 
in that range -- tested positive. I assume that the U.S. Post 
Office continued that program. 
I'm wondering what the percentage might be today? 
COL. WALLACE: Sir, the Post Office went into another 
experiment where they went out and recruited known drug abusers, 
and then put them through a rehabilitation program, and then 
measured their job performance compared to the general 
population. 
I've got a study out of NIDA that tracks the two 
populations in terms of absenteeism, on the job accidents, 
disciplinary infractions. And I'll be happy to see to it that 
that's provided to your Committee, sir. 
CHAIRMAN SEYMOUR: Very good. 
Well, I admire the work you've done, Colonel Wallace, 
and certainly the spirit I catch in the program, and it's so 
important that you designed the program that way, and that the 
M President wanted it designed that way. It is obvious we're 
27 concerned with the rights of individuals. But the protections 
2X 
you re 
lO 
!4 
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set up for the employees, and the employee assistance ' 
you've set up for the employees, and all those 
ions once you get over that shrill voice of oh, 
re invading my body -- and really take a look at what 
, boy, it's commendable. It's super. 
COL. WALLACE: Thank you, Mr. Chairman. 
CHAIRMAN SEYMOUR: I wish our State were.as advanced. 
Thank you, Colonel. 
All right, we're going to take a 15-minute break, and 
' l reconvene. 
(Thereupon a brief recess was taken.) 
CHAIRMAN SEYMOUR: Our next witness is Shawn Marcell, 
Manager for Abbott Laboratories. 
Mr. Marcell, thank you for being with us today. 
MR. MARCELL: Good afternoon, Mr. Chairman. 
you for the chance to be here today on behalf of 
ies. My name is Shawn Marcell. I'm U.S. Product 
the Analytical Systems Group of Abbott Diagnostics, 
, Texas. 
so with me here today is Jane Nakagawa, who is based 
ramen to. 
is a multinational health care products 
, headquartered in North Chicago, Illinois, and 
ly 38,000 people worldwide, and 2,000 people 
State of California. 
is the world leader in diagnostic medicine, the 
icated to laboratory testing, with products in such 
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diverse areas as hepatitis and AIDS testing, cancer monitoring, 
clinical chemistry, therapeutic drug monitoring, and drugs of 
abuse testing. 
I'm here today to comment on one of the Committee's 
concerns on new developments and technological advances related 
to chemical testing for drugs and alcohol. And rather than 
having you go and visit a laboratory, we brought the laboratory 
here to show you today, which will illustrate a point that I'm 
going to make. 
In talking about the Committee's concern, I'd first like 
to discuss: the scope of the drug problem, particularly as it 
relates to the workplace; the evolution of drug testing 
technology; and finally, the applications of drug screening. 
The scope of the drug problem can hardly be overstated, 
as the Committee is well aware and has heard on the preceding 
days. Employees who abuse drugs and alcohol are five times more 
likely to be involved in accidents, use health care benefits at 
four times the rate of non abusing employees, and are several 
more times likely to be involved -- to be absent from the job. 
Several public interest groups have attempted to 
21 quantify the cost to society resulting from the drug problem. In 
22 1986, the Research Triangle Institute estimated that drug abuse 
23 alone had an aggregate cost to society of over $80 billion. And 
24 as you noted earlier, $18 billion of that was here in the State 
25 of California. And that alcohol abuse costs society 
26 
27 
28 
approximately $150 billion a year for some of the reasons 
outlined above. 
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Because of the far-reaching effects and the significant 
costs of drug and alcohol abuse, there have been many 
s to control the problem. Among these efforts is drug 
, which is now widely recognized as one of the most 
means of identifying, treating, and helping to prevent 
substance abuse in the first place. 
test 
This recognition has led to widespread use of drug 
many different areas by many different organizations 
to protect the populations that they serve. Among them 
criminal justice system, which includes: adults and 
le probation, parole programs, jails and prisons, pretrial 
lease services, and other correctional facilities. Drug 
treatment and rehabilitation programs, hospitals, employers and 
test_ 
·As 
ions, the U.S. military, organized sports, and many other 
izations who, just a decade ago, would not have considered 
for drugs. 
Abbott is involved with many of these organizations, and 
lude groups such as: the United Olympic Committee; TASC, 
ternatives to Street Crimes, which is part of the 
Justice assistance; American Parole and Probation 
International Narcotic Enforcement Officers 
at American Corrections Association; the list goes on. 
Opponents of drug testing have raised questions about 
f tiveness. To answer whether drug testing actually 
sider these examples. 
First, the case of Commonwealth Edison, a Chicago-based 
ic utility, who experienced a 25 percent decrease in 
ism after instituting a drug testing program in 1982. 
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Or the case of the Georgia Prison System, where an 
11-fold decrease in monthly episodes of violence was experienced 
after instituting a drug testing program among the guards and the 
inmates. 
And probably the most obvious example is the one we've 
already heard here today, the success of the U.S. military drug 
testing program, which led to just a phenomenal decrease in 
initially positive results after it was instituted in the early 
1980s. 
Unfortunately, there's been a large gap in drug testing 
technology. On one hand, there's a huge and growing demand for 
accurate, high quality drug screening. That's the initial drug 
test. On the other, there have been enormous limitations with 
the early drug testing technologies, which has contributed 
significantly to the negative public opinion of drug testing. 
A review of the evolution of drug testing technology 
will be helpful in illustrating this point. The first 
commercially available drug testing technology, developed in the 
1960s, was called thin layer chromatography, or TLC for short. 
This was the first commercial application of drug testing, and 
although it was capable of testing for a large number of drugs, 
22 this method has relatively poor sensitivity. In other words, it 
23 can't go down to very low levels. It's also labor-intensive, 
24 which makes it unsuitable for on-site testing. It requires a 
25 subjective interpretation of results; meaning the operator has to 
26 actually make a personal determination on a positive. It also 
27 requires the handling of volatile chemicals and is generally 
2H considered fairly technique or experience dependent. 
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In the early 1970s, the enzyme immunoassay method, also 
known by the brand name EMIT, was developed and introduced 
as the first immunoassay for drug screening. And although 
say is considered the state of the art, it was introduced 
'back n '70s. 
The EIA or EMIT test overcame some of the problems of 
its predecessor, thin layer chromatography, but had its own set 
tations. Still was the problem of poor sensitivity, 
not being able to go down to low levels, and also the 
of specificity, meaning cross reacting with unwanted 
, or not being specific for the compound or the drug or 
that is being tested for. This led to a tendency to 
ate false positive.and false negative results, which again 
,contr to public fear of drug testing. EIA is also somewhat 
the 
-dependent and requires precise chemical manipulations. 
During the late 1970s, in response to a call for more 
and reliable drug screening technology for applications 
.S. military, the radio immunoassay method was developed. 
, RIA overcame the accuracy problems of its 
s, but had its own set of limitations, such as the 
special handling and licensing requirements because 
ioactive components. It also demands a high degree of 
expertise and is considered very labor-intensive, 
has to be relegated to commercial laboratories. 
This brings us to the drug testing environment of today, 
characterized by widespread drug abuse, an explosion in 
for drug testing, controversy because of significant 
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limitations of the older drug testing technologies, and a demand 
for rapid, accurate, and very easy to use drug testing 
technologies. 
In response to this situation, Abbott pioneered a new 
generation of drug testing technology using a new, more sensitive ! 
and more specific technique called fluorescent polarization 
immunoassay, or FPIA for short. FPIA made its commercial debut 
in 1982 for the precise analysis of powerful, high risk, 
therapeutic drugs used to treat a variety of conditions such as 
heart disease, epilepsy, asthma and cancer. Since then, FPIA has 
become the most widely used drug testing technology in the world, : 
with over 15,000 system placements worldwide. Today, over 
three-fourths of all hospitals in the United States use FPIA. 
In 1986, this technology was successfully extended to 
the detection and screening of drugs of abuse in urine, including 
alcohol, which, for the first time, makes drug testing not only 
highly accurate and rapid, but extremely easy to use. And for 
the first time, suitable for on-site immediate drug testing. 
In developing these systems, Abbott attempted to 
overcome major technological limitations of the other testing 
methods and to respond to a new and changing drug testing 
environment, which is, I think you'll agree, one characterized by 
1 
diversity and a great deal of need for on-site, immediate drug 
24 testing results. This represented a natural evolution in 
25 technology, similar to what's taken place in other industries 
26 such as the computer industry and consumer electronics. 
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During clinical trials, FPIA systems showed virtually 
correlation with the reference methodology, gas 
romatography/mass spectrometry, or GCMS, which was mentioned 
lier and is considered to be the only definitive drug 
firmation method. 
Today, initial drug screening can either be conducted on 
,site 
1: 
as you know, contracted to an outside commercial 
labor 
I 
Because of expense and the technical expertise 
II 
,I red, confirmatory procedures should always be contracted to 
a 1 clinical laboratory. 
It is important to realize that all laboratories, 
however, are not created equal, and that there can be significant 
~variations in quality and service. 
I 
Some helpful questions to be 
asked of laboratories prior to consideration are: 
First, what screening methods does the laboratory use? 
Is it performed according to the manufacturer's FDA-approved 
spec f ions? Can the contracting agency choose the test 
Second, what method is used to confirm initially 
si specimens? In other words, the only generally accepted 
is GCMS, and that should in all cases be the response. 
Third, is each specimen treated with a documented chain 
f cus procedure? Are specimen storage areas secure and with 
access, and allowing for limited access? Is the 
staff trained on each piece of equipment and certified 
,to perform all the procedures for which they are responsible? 
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At a minimum, these important questions should be 
answered fully prior to contracting with a laboratory. A site 
visit to inspect the facilities and meet personnel is also 
worthwhile. 
49 
A trend toward performing initial testing, a screening 
test, on site, again with confirmations being sent to an outside 
laboratory, has developed because of some significant advantages 
to on-site testing. This has been made feasible largely because 
of advancements in technology. 
Examples of where testing is now widely performed 
on-site include: parole departments throughout the country; 
probation departments; rehabilitation and treatment programs; 
corporations -- in fact, Abbott Laboratories has its own on-site 
screening program -- sports testing; the military; and so on. 
The reasons are pretty simple. There are several 
powerful advantages to on-site testing which I'll summarize. 
First, the turnaround time. Since the vast majority of 
the specimens generally test negative, anywhere between 70 and 98 
percent usually test negative, by testing them on site, this 
major portion can be eliminated right up front without having to 
transport a huge number of specimens to an outside laboratory, 
just those testing positive for confirmation. 
Next is specimen integrity. Transporting only a few 
specimens that screen positive to an outside laboratory, which 
amount to a vast minority, offers greater control in handling and 
preserving the specimens prior and after testing. And also 
.greatly reduces the risk of loss and damage. 
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The third is decision making. A faster turnaround time 
on the negative specimens means that there's no delays in, say, 
hir or extending an offer for employment, or to expedite 
counseling in the case of a rehab. facility. It would expedite 
cou 1 in the criminal justice system or to correct a 
lem. 
Next is confidentiality. By conducting the screening on 
site, the institution may control and manage the results without 
reliance or without reliance on outside sources. Often the 
comes up that they don't want people who work for the 
or work for the agency testing the same employees. But 
argument really applies both ways. Those are the same 
people that have to manage the test results if they came back 
14 from a laboratory. So, the point is, it doesn't really matter 
!5 they're actually performing it on site or sending it out 
~~ , to a laboratory, because the handling considerations of the 
17 s as well as the results are equal. 
1 H 
26 
2X 
Next is method control. As mentioned earlier in the 
statement, there's a documented variation in the performance of 
rent drug screening methods. Sending specimens to an 
laboratory usually means accepting the screening method 
that laboratory, and hence reduces the agency's or 
lity to control the quality of the results. site's 
Last is chain of custody. By transporting substantially 
imens to outside sources, there is proportionally less 
of a break in the chain of custody, less documentation 
red, and less opportunity to lose or damage specimens. 
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We believe that testing technology will continue to 
advance, making faster, accurate and more reliable drug screening 
widely available. The advent of new technology shows this to be 
true. 
The trend should not be hampered by inflexible 
regulatory guidelines. Government agencies and private employers 
should be free to take advantage of advances in technology to the 
benefits of the populations that they serve. We find this 
especially true where the need to preserve public safety is 
compelling, and where significant gains to employers and 
employees alike can be realized. As in the past, Abbott would 
like to act as an information resource. Part of Abbott's overall 
leadership position includes commitment to education. 
I've brought with me some of the items published by 
Abbott which are made available to you. Some of them concern 
practical approaches to drug testing in the workplace, setting up 
policies, questions to ask laboratories. I've brought with me 
pieces that compare and contrast and evaluate drug testing 
technologies so that the most informed decision, based on the 
needs of a particular testing site, can be made. There is other 
information regarding drugs, the relationship between drugs and 
22 crime and the criminal justice system. Additional resources are 
21 also available. 
24 On behalf of Abbott Laboratories, I'd like to thank you, 
25 Mr. Chairman, and the Committee for the opportunity to be here 
26 today. If there are any questions relating to this statement, 
27 I'd be happy to answer them now. 
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Also, I'd like to add that, if you'd like to see a 
demonstration of the new technology, we'd also be happy to do 
that. It won't take very long. 
CHAIRMAN SEYMOUR: How much time would that take? 
MR. MARCELL: A couple of minutes. 
CHAIRMAN SEYMOUR: Go ahead. 
MS. NAKAGAWA: Mr. Chairman, Abbott's drug detection 
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' system, the ADX, is fast, accurate, sensitive, and extremely easy 
to use. All that's needed is basically just three steps. 
First, you would load the carousel by placing in the 
pack, followed by a cup and cuevette, another cup and 
cuevette if you have another sample, or a reagent pack of your 
choice. In this particular example, it's a panel of five. You 
could also do a panel of ten, or several smaller panels. It's 
extremely flexible. 
The second step, you would just place it into the 
instrument, close the door, and press the panel. At this point, 
you can walk away. The instrument does everything for you. It 
works off of a microprocessor. Before each run, it does several 
initial checks to ensure that everything is working properly. 
In about 20 or 30 minutes, your panel will be done, and 
a hard 
That's it. 
printout, we print it for you for your records. 
CHAIID4AN SEYMOUR: So, the machine doesn't take any 
25 spec 1 training per se? 
26 MR. MARCELL: It requires no operator-dependent steps. 
27 There's nothing that requires a technique or scientific training. 
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We tried to make it -- in developing it, we found the 
biggest problem conveyed with our customers was, they didn't want 
several different people running an instrument. They all had 
different levels of training. They wanted something that met a 
common denominator that everybody could run. 
CHAIRMAN SEYMOUR: Very impressive. 
MS. NAKAGAWA: The instrument does all the pipetting and 
everything for you. There's really nothing to do. All you do 
is, you need to pour the sample on. 
CHAIRMAN SEYMOUR: How accurate is it? 
MR. MARCELL: In clinical trials, it compared 99.9 
percent with GCMS. 
CHAIRMAN SEYMOUR: Thank you very much, Mr. Marcell. 
MR. MARCELL: My pleasure. 
CHAIRMAN SEYMOUR: Is Norm Wade, Chief Toxicologist for 
the California Department of Justice here? Please come forward, 
Mr. Wade, and we'll take your testimony. 
Thank you for taking the time to be with us. 
MR. WADE: Thank you. 
My name is Norman Wade. I am Chief Toxicologist for the 
California Department of Justice. 
On behalf of the Attorney General, I would like to thank 
you for welcoming us here to address the Committee today. 
The Attorney General is very interested in drug testing. 
As you might know, the Attorney General has under his command a 
Division of Law Enforcement, which includes the Bureau of 
Forensic Services, which is actually the lab system or the crime 
lab system throughout the State of California. 
2 
6 
We have nine existing lab locations, and one existing 
toxicology lab here in Sacramento, of which I am in charge. 
54 
I have 18 years' experience in forensic toxicology, and 
I'm a board-certified forensic toxicologist. Also, I've worked 
as an advisor to the armed forces, including the Army, the Navy, 
and the Air Force, and the FBI, and also in private labs that 
have done testing for FAA and other federal employees. So, I 
feel like I have experience in the field of forensic toxicology. 
7 
X 
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II 
I also have contacted Mr. Morford and Mr. Strom back in 
February of this year per advice of the Attorney General to offer 
12 
my ise in forensic toxicology, whatever they might need. 
found upon talking to them, as you did, Mr. Chairman, they were 
already prepared anyhow. They didn't need my expertise at all. 
Incidentally, a forensic toxicologist is someone who 
determines the amount of poisons or drugs in biological fluids. 
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So, I am board-certified, of which there are only about 200 of us ' 
in the country. 
And also, to give you some idea as to what we do, I did 
1'-J the on the Elvis Presley homicide or suicide, and I can 
20 assure you, Mr. Chairman, he is definitely dead. 
2 CHAIRMAN SEYMOUR: Can you show us what drugs he had in 
22 his system? 
2.\ 
24 
25 
MR. WADE: Yes, I could name some drugs for the record. 
CHI\IR!v1AN SEYMOUR: Never mind. 
MR. WADE: The Division of Law Enforcement and the 
26 Bureau of Forensic Science primarily does driving under the 
27 influence cases. Last year, we did 55,000 breath alcohol cases; 
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22,000 blood or urine alcohol tests; and about 3500 toxicology 
tests. We had about a 60 percent positive rate, so if the 
question is: are drugs prevalent in California, the answer is 
yes. In fact, in a national survey of the clandestine labs that 
were seized in all the United States, labs that were illicitly 
manufacturing illicit drugs, such as PCP or methamphetamines, 
two-thirds of the clandestine labs are located in California; 75 
8 percent of those labs were methamphetamine labs. So yes, 
9 California has a problem. 
10 The most popular drugs in California are, in their order 
11 that we have found: marijuana, methamphetamine, cocaine, and 
12 PCP. These seem to be coincidental to the area of the state 
13 where the drugs are located. Methamphetamines and marijuana seem 
14 to be concentrated in the northern part of the state; cocaine 
15 seems to be concentrated around Marin County and the Monterey 
16 area; and PCP seems to be concentrated in Fresno, Riverside, and 
17 the L.A. area. 
18 We use different procedures for testing for drugs. We 
19 use radio immunoassay; we use gas chromatography, and we use gas 
20 chromatography/mass spectrometry. And I can assure you --
21 CHAIRMAN SEYMOUR: Excuse me. 
22 Of those, which do you find to be the most reliable? 
23 MR. WADE: Well, radio immunoassay is very specific but 
24 is not very -- I'm sorry, very sensitive, but not very specific. 
25 That is, you can detect a very low level, but you might have some 
26 cross reactivity. 
27 
28 
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So in answer to your question, by far gas 
2 
chromatograph/mass spectrometry is by far the best. 
We have four gas chromatography/mass spectrometers that 
4 
range in price from $70,000 to $350,000. So, it just depends 
5 
upon the sensitivity as to what you want to look at. 
6 
So, we use these three procedures: radio immunoassay, 
7 
gas chromatography, and gas chromatography/mass spectrometry, and 
8 we find many, many drugs. And we feel that really the only way 
9 to confirm these drugs exist is with the GC/mass spec., which has 
10 been considered the gold standard, because it gives an 
II elucidation of the chemical structure of a compound. Much like 
12 you would take a piece of dynamite and put it in your back pocket 
IJ and blow yourself up, you would form fragments. These fragments 
14 would be the same way every time. The same thing happens to 
15 chemical molecules. Each time you bombard these chemical 
16 molecules with a stream of electrons, they fragment the same way. 
17 So, you really get a very good fingerprint of the particular 
18 molecule you're looking at. 
19 Also, it's very, very sensitive. We can detect down to 
~) a half an anagram per mil in marijuana in blood analysis. 
21 Now, in talking about the NIDA guidelines, or the 
22 gu lines that have been adopted by the Department of Personnel 
~ 1 Administration and the State Personnel Board, essentially the 
"--' 
M ~ testimony that has been given so far by Colonel Wallace and some 
G 
25 i of the other people was quite true. The testing really did start 
26 in 1982, when it was found that the Navy did not really have a 
27 testing program that was really quite up to par. So, that it 
28 
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began to really emphasize quality control, and a very strict 
chain of custody, and a very strict means of identifying certain 
compounds. 
I was involved in that process. Since then, these NIDA 
guidelines have essentially followed the Navy guidelines, which 
were written in about 1983, and they're very close to the College 
of American Pathologists guidelines also. 
So, I can assure you, Mr. Chairman, in my expert 
opinion, that any laboratory that passes the NIDA guidelines 
certification, or the College of American Pathologists 
certification, is in fact and indeed a very good laboratory, and 
in fact is, in my opinion, from a chemical and a toxicological 
standpoint, very adept at detecting drugs in biological fluids. 
Now, I mentioned radio immunoassay. We do also have 
fluorescent polarization immunoassay. In fact, the piece of 
equipment that's sitting before you on the table is our piece of 
equipment. We loaned it to the people from Abbott. So I can 
assure you that --
CHAIRMAN SEYMOUR: I hope you got yourself a reduced 
2o rate on the equipment. 
2l MR. WADE: I can assure you that this particular 
22 procedure is also equivalent to our RIA. 
2.1 I somewhat differ in the representative from Abbott, 
24 Mr. Marcell, in that I really think that testing really ought to 
25 be done on site, and confirmation should be done on site at one 
26 particular site, as is stated in the NIDA guidelines and both the 
27 College of American Pathologists guidelines. I really think it 
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should be done under the direction of a trained, board-certified 
forensic toxicologist, and it should be very highly quality 
controlled. 
And lastly, I think some of the things that Mr. Wallace, 
or Colonel Wallace, brought up is absolutely true. I believe 
random testing is by far the best method for testing whether the 
person is actually using the drug. There are various means to 
get around testing if one knows that testing is coming up, from 
drinking lots of liquids, to taking any type of diuretic, or just 
simply laying off of drugs for a while. And also, the fact that 
urine samples are going to be used indicates that some drugs can 
be found in urine up to about 30 days after they've been inhaled, 
particularly marijuana. So, I think that both of these areas 
where Colonel Wallace has pointed out are very true. 
I think what we look at in forensic toxicology is 
impairment. That is, we have a field sobriety test administered 
by a CHP officer. We have --obviously, if a person opens the 
door and falls out of the car, they're obviously impaired. 
That's going to be a problem, I think, in employee drug 
'testing, to show that the person was impaired on the job. But 
the mere fact the person's using a drug, the fact that it's a 
hard , he shouldn't be using it anyhow in no way negates the 
fact we should not do drug testing on employees. 
CHAIID~AN SEYMOUR: Thank you very much. We appreciate 
your testimony. 
Our final witness would be Harvey Collins, Ph.D., Deputy 
Director for Public Health, State Department of Health Services. 
2 
4 
5 
6 
7 
9 
10 
J, I 
12 
14 
15 
16 
17 
18 
19 
20 
21 
22 
24 
25 
26 
27 
28 
1/ 
I! 
II 
lr 
DR. COLLINS: Thank you, Mr. Chairman, for the !! i/ 
II 
1/ ~opportunity to appear before your Committee on behalf of the 
!i, 
I' 
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li Department. 
~ For the record, my name is Harvey Collins. I'm Deputy 
II ,!Director of Public Health within the Department of Health 
il 
[f Services. 
II 
I will be presenting the Department's responses to the 
!!questions you asked of Dr. Kenneth Kizer in your letter, dated 
!october 12th, 1988, to address. 
1
1 CHAIRMAN SEYMOUR: Thank you. 
~ DR. COLLINS: In the interest of clarity, I will restate 
11 the question and then provide you with the Department's response. 
II 
II 
li 
II /; 
II 
'I I, 
The first question: 
"What are the current DHS, or Department 
of Health Services, laboratory certification 
procedures?" 
II ~ DHS operates a program whereby it licenses and certifies 
!laboratories which provide services in urine drug testing to 
~patients of methadone treatment programs. 
li 
I
I Methadone treatment programs are conducted by privately 
1ioperated organizations which administer the substance, methadone, 
[jto persons addicted to heroin during treatment to aid these 
llpatients in altering life styles and to eliminate dependency on 
li 
11 drugs. 
II 
II 
I 
11 
il 
As you know, administration of the substance, methadone, 
liis performed in order to overcome symptoms of heroin withdrawal 
li 
~during treatment. Methadone treatment programs use the results 
~of periodic urine drug tests to assess objectively the 
II 
II 
il 
I! 
II 
!I 
!i 
\i ,, 
7 
H 
9 
10 
II 
12 
ll 
14 
15 
16 
17 
IX 
effectiveness of counseling and other treatment to remove a 
patient form a state of drug dependency. 
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The operating standards for methadone treatment programs 
are assigned by the Health and Safety Code to the Department of 
Alcohol and Drug Abuse. The operating standards for laboratories 
which provide testing service to methadone treatment programs are , 
consigned to the Department of Health Services. This requirement 
is specified in Section 11881 and Sections 11885 through 11896. 
These standards are set forth in Title 17, Code of Regulations, 
Sections 1160 through 1196. 
In administering the regulations, DHS reviews personnel 
qualifications, performs detailed review of a laboratory's test 
methods, conducts monthly blind proficiency tests, and performs 
on-site inspections of laboratories' operations. In this 
, program, laboratories must be capable of reliably testing for 
methadone, amphetamines, barbiturates, and the two opiates heroin 
and codeine. The DHS certification program evaluates and 
certif s the proficiency of the laboratories to perform these 
19 analyses. 
20 The question question: 
21 "What is the feasibility of DHS 
~~ certification of drug testing 
2~ laboratories?" 
24 It is feasible for the Department to certify 
25 laboratories doing drug testing for employment purposes. It can 
26 !! be most easily accomplished by basing California certification 
27 ~ upon the approval of a laboratory by a national accrediting 
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organization, such as the National Institute for Drug Abuse 
Accreditation, or its equivalent. 
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To ensure the continued acceptability of the 
accreditation program, the Department could provide for the 
conditional approval of all or parts of the program and assess 
the effectiveness of the component parts -- chain of custody, 
technical performance, proficiency testing, et cetera -- through 
our own on-site monitoring. 
If all or a portion of the accrediting program was found 
unsatisfactory, the Department could withdraw approval of the 
unsatisfactory portion of the accrediting program, or the entire 
program if necessary, and institute its own accreditation 
program. In the latter instance, fiscal support would be 
required for administration of the program. A State-operated 
accreditation program should be fee-supported. 
I might add that the Department has quite a bit of 
experience in certifying various environmental laboratories, for 
example. And if, during the accreditation procedure, a certain 
laboratory does not perform adequately in a particular area, then 
one might pull just that part of the certification program, 
whereas the laboratory might be allowed to continue analyzing 
other constituents that it had been previously certified for. 
The final question: 
"What is the role of DHS in the 
implementation of the State drug 
testing policies?" 
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DHS, like all other departments and agencies, reviewed 
and provided input to proposed DPA and SPB rules relative to both 
preemployment drug testing of applicants for sensitive classes, 
and drug testing of employees where drug abuse was suspected. 
When these laws and rules are adopted, the Department will have 
the ongoing responsibility of ensuring compliance. Additionally, 
like all other State departments and agencies, DHS has 
established an employee assistance program which provides 
referral counseling services for employees with drug-related 
problems. 
That concludes my prepared remarks, Mr. Chairman. I'd 
be glad to try to answer questions if I can. I do have staff 
·.with me from the Department to help in answering specific 
questions. 
CHAIRMAN SEYMOUR: How many employees does the State 
Department of Health Services have? 
DR. COLLINS: I would guess around 4,000, approximately. 
CHAIRMAN SEYMOUR: Has the State Department of Health 
Services, under the leadership of Dr. Kizer, concluded any 
decision at all relative to what that Department's policies will 
be? 
DR. COLLINS: Not to my knowledge but let me ask Joan 
23 Allison to come up and try to address that. Joan is with our 
24 
1 personnel. 
25 CHAIRMAN SEYMOUR: Thank you very much. 
Joan, welcome. 
27 MS. ALLISON: Thank you. 
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I would have to actually agree with Dr. Collins in terms 
of the Department not having established formal policies at this 
point in time. I think until fairly recently, both DPA and SPB 
have been reviewing their proposed guidelines, and we've been 
kind of waiting on some finalization of those laws and rules. 
I believe a package of, again, some modifications of 
some rules that they have proposed just went to the State 
Personnel Board itself for their review in September. And the 
departments have not been notified whether or not those 
modifications in fact have been were formally and fully 
adopted as they were proposed. 
So, I think probably Health Services, like most other 
State departments, we're kind of still waiting to see what the 
final determination from the control agencies is going to be 
before we develop our internal policies. 
CHAIRMAN SEYMOUR: Thank you. 
Dr. Collins, when you were reading your answer to the 
last question, you used the same word that I heard from the State 
Personnel Board as well as the DPA, and that word was 
"sensitivity." 
My question is this: did the Personnel Board or DPA 
22 instruct you, not ask your opinion, but did they instruct you to 
23 be responsible to carry out policy in only those areas? 
24 
25 
26 
DR. COLLINS: No, sir. 
CHAIRMAN SEYMOUR: Or is that your word? 
DR. COLLINS: No, in all candor, Joan Allison prepared 
27 the response to that question. 
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MS. ALLISON: I can respond to that. 
CHAIRMAN SEYMOUR: Please. 
MS. ALLISON: Essentially when DPA and SPB were 
64 
. beginning their work on trying to adopt rules in this area, they 
essentially instructed every department to identify classes that 
fell into a sensitive category. That is, those where --
CHAIRMAN SEYMOUR: Here's the point I'm trying to make, 
Joan, and maybe you can help me. It may be a simple yes or no. 
It sounds to me like the State Personnel Board and DPA, 
early on, decided they would only go after these sensitive jobs. 
MS. ALLISON: Yes. I think that's certainly the message 
·the departments got, and they defined what sensitive was. 
I do know at Health Services, for instance, we did 
identify several classes for inclusion in that category that we 
were subsequently told did not meet that criteria. 
CHAIRMAN SEYMOUR: Thank you very much for your 
testimony. 
DR. COLLINS: You're welcome. 
CHAIRMAN SEYMOUR: To each and every witness that has 
testified today, and particularly the one that carne the furthest, 
. Colonel Wallace, I want to sincerely thank you for your 
cooperation. 
This whole field, I guess what I said in the opening 
statement I've always believed. It isn't a question of are we 
'going to test or are we not going to test. That's a long, 
foregone conclusion. It's how, and what protections are going to 
;be there for the employer and the employee. 
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We have one more hearing on this subject tomorrow in San 
Francisco. And I can already begin to conclude, unless the 
information or testimony received in San Francisco -- it may be 
different, I suppose, but if it runs similar to this, we'll be 
hearing from labor and management and the private sector, and 
!i probably the ACLU, I don't know, all kinds of groups there. 
But it seems to me that much, much has been accomplished 
in moving ahead in the last two years. I'm surprised, and 
particularly impressed, Colonel Wallace, by the federal program. 
You are on the cutting edge. I would suspect what you're doing 
with federal employees probably is on the cutting edge of the 
private sector as well. I'm amazed a government of that size can 
move that fast. 
COL. WALLACE: We certainly have a number of lawyers 
fully employed, sir. 
CHAIRMAN SEYMOUR: Thank you very much. 
(Thereupon this interim hearing 
of the Senate Select Committee on 
Substance Abuse was terminated at 
approximately 4:20 P.M.) 
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1 P R 0 C E F D I N G S 
2 -·-oOo--
3 SI~Nl'-.TOR SEYf10UR: Ladies and gentlemen, good 
4 afternoon. We will convene this interim hearing of the 
5 Senate Select Committee on Substance Abuse. 
6 I'm ~tate Senator John Seymour. I'm Chairman 
7 of that Select Committee. The subject of this 
8 afternoon's hearing is drug testing in California, how far 
9 have we come? 
10 After five years of extensive involvement in the 
11 area of drug and alcohol abuse, I find myself in agreement 
12 with the many experts in the field who say that substance 
13 abuse in the workplace has become pervasive. 
14 Indeed, it is not overkill v.1hen I say it has 
15 reached epidemic proportions. The result has become 
16 clear. The energy, efficiency, and honesty of the 
17 American workforce is being diluted. 
18 Unfortunately, while labor and management 
19 debate the merits of various methods of curtailing 
20 vJOrkplace substance abuse, manv innocent citizens and 
21 fellow employees are being injured and sometimes killed 
22 by the accidents or mistakes of an employee vwrking under 
23 the effects of a mind-altering substance. 
24 I find myself asking more and more how can 'de 
25 explain to the families of those victims killed when 
26 Conrail trains collided, that this tragedy was not a 
27 result of mechanical malfunction or human error, but 
28 rather drugs ingested. 
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1 Furthermore, ho\.17 do v:e explain to the public 
2 that there could be a nuclear accident because an 
3 employee at the controls was high on dope? 
4 Finally, how do we explain to our children the 
5 pervasiveness of drua use by their heroes -- basketball 
6 stars, football players, TV and movie stars, and even 
7 the Olympians? 
8 Now, after extensiv~ involvement and lengthy 
9 deliberation, I am convinced that drug testing in the 
10 workplace is but one of the steps necessary for solving 
11 this nation's substance abuse problems. Not only are 
12 alcoholism and drug addiction deadly human diseases, 
13 much the same as tuberculosis, cancer, AIDS, and 
14 Alzheimer's, they ar~ also deadly socioeconomic diseases 
15 which cost the State of California over $18 billion each 
16 and every year. To put it another way, that's over $700 
17 annually for every man, woDan, and child. 
18 This high price tag is attributed to employee 
19 absenteeism, lowered productivity, defective goods, plus 
20 accidents that result in higher medical and insurance 
21 costs. It is estimated that over 20 percent of our v1ork-
22 force is under the influence of drugs or alcohol in the 
23 workplace. 
24 One of the questions that I'm frequently asked 
25 when talking about substance abuse testing legislation is 
26 whv do we need law in this area? ~hy can't we leave 
27 things just as they are? 
28 Todav, because there is no law setting the 
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1 parameters under which testing ,,lill take place, employers 
2 and employees are flying blind as to their rights. 
3 This has led to a ~roliferation of lawsuits, 
4 which is causing the courts to write the law in this 
5 field rather than the Le~;·islature. Both employees and 
6 employers need protection from blatant disregard of 
7 constitutional rights. 
8 Approximately 22 percent of California's 
9 workforce are tdday represented by labor unions and 
10 protected, therefore, by collective bargaining agreements. 
11 However, without lavJs setting up the parameters under 
12 which the employer raay conduct drug testing, who is going 
13 to protect the other 78 percent of the \vorkforce v.rhich is 
14 not represented by organized labor? 
15 Yet another question that is constantly raised 
16 is, should it take place at all? I'd like to share with 
17 you that this question has already been resolved. Drug 
18 testin<_:r in the vvorkplace is here to stay. So, I would 
19 sugqest that the question is not if, but rather how. 
20 For these reasons, I introduced legislation 
21 in 1986 and again in 1987, which would have set up the 
22 parameters under which an employer could conduct drug 
23 testing programs. 
24 Tv.;ro bills I introduced in 19 8 7, neither of 
25 which mandated testing, were the products of discussions 
26 with lawyers, doctors, experts on the tests, and 
27 representatives of both labor and management. 
28 Senate Bill 1611 would have allowed employers to 
PETERS SHORTHAND REPORTING CORPORATION 
3336 BRADSHAW ROAD. SUITE 240 
SACRAMENTO. CALIFORNIA 95827 
4 
1 conduct testina of job applicants and testing of 
2 current employees if the em:oloyer had reasonable suspicion 
3 that alcoh61 or controlled substances were present in an 
4 employee's body while that em:)loyee ~vas in the workplace. 
5 The second bill, Senate Bill 1610, would have 
6 allm·Jed an employer to conduct random testing only where 
7 the eJ11ployee was employed in a high risk or safety 
8 sensitive position, a position in which he might endanger 
9 himself or herself, other employees, or the public at large 
10 Both of the ·bills set forth the ?arameters under 
11 which a substance abuse testing program could be conducted 
12 by an employer. The bills contained protections for the 
13 ernployer and the err.~loyees in both the public as v,rell as 
14 private sector. 
15 I believe that these bills represented a 
16 realistic approach to drug testing and struck the 
17 ai_>propriate balance betv.reen the er.tployer' s right to 
18 ensure for himself or herself, as \vell as their employees, 
19 a drua free work environment and at the same time protect 
20 the er:1ployees' individual rights. 
21 Unfortunately, both of the bills were killed by 
22 the Senate Industrial Relations CormJ.i ttee and, in fact, no 
23 drug testing bill has been passed by the Legislature to 
24 this date. 
25 The purpose of this hearing today is to receive 
26 input from the experts on whether legislation should be 
27 reintroduced and pursued to once again attempt to set up 
28 the parameters for drug-testing programs to ensure that we 
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1 protect the emplo';ees, the employers, as ,,rell as the 5 
2 public. 
3 You'll hear from leaal experts as to how judges 
4 in California and throughout the nation are ruling on 
5 various drug-testing Drograrns which have been challenged 
6 in court. 
7 We will hear from labor and management on their 
8 feelings regarding drug testing and whether there's been 
9 any change in the opinions of the leaders in these 
10 fields since the deliberations on my original legislation. 
11 And finally, we \'.rill also have testimony from 
12 the experts on the tests themselves used for determining 
13 whether a person has controlled substances in the body. 
14 rJe'll also receive an update on the new technologies and 
15 current accuracy rates of these tests. It is my hope 
16 that the testimony at these hearings vrill tell us hm'r 
17 far we have come since we last examined this issue and 
18 how much further we may have to go in order to make 
19 certain that drugs in the workplace become the exception 
20 rather than the rule, and to accom~Jlish this by ensuring 
21 that fair and responsible guidelines are established. 
22 Our first witness today is nr. Victor 
23 Schachter, Attorney at Law, with Schachter, Kristoff, Ross, 
24 Sprague & Curiale. 
25 Mr. Schachter. 
26 MR. SCEl\CETER · Good afternoon, Hr. Chairman. 
27 and thank you for coming to Gan ~rancisco to give us an 
28 opportunity to share our views with you and, in turn~ with 
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1 your Committee. 6 
2 I'm an employment law attorney and have been 
3 heavily involved in the drug-testing litigation 
4 representing enployers over the years. And I am appearing 
5 here today on behalf of the California Employment Law 
6 Council, a state"~c·7ide nonprofit organization composed of 
7 over 60 employers representing a broad segment of the 
8 California em;::>loyer community. 
9 Its members employ over 400,000 employees in the 
10 State, many under collective bargaining agreements. CELC 
11 has been very concerned that any drug-testing legislation 
12 under consideration be well balanced in its direction and 
13 uniformly applied throughout the State consistent with 
14 due process safeguards. 
15 I would like to make a few remarks concerning 
16 the legal developments concerning drug testing, and then 
17 make some observations of where CELC hopes that future 
18 attention will be directed by the Legislature. 
19 For the first time in its history, the United 
20 States Supreme Court is going to consider the legality and 
21 constitutionality of drug testing in the workplace. In 
22 fact, on November 2nd, a very short time from how -- next 
23 week ---- the t\·70 cases which will be first considered by 
24 the United States Supreme Court in the area of drug 
25 testina will be orally araued. 
26 That is the Von P.aab case and the Burnley case. 
27 Jn the Von ;:>_aab case. the issue of whether or not 
28 individuals that are in pubU c service and who are promoted 
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1 to security-sensitive positions in this case, drug 7 
2 enforcement responsibilities in the Customs Service 
3 can be required to undergo a drug screening without 
4 violating their constitutional rights to be free from 
5 unlawful search and seizure. 
6 In the second case, the Burnley case, they are 
7 also dealing with a public sector case. But the issue 
8 there is whether or not -- in this case, the railroad 
9 industry -·- under public regulations has the right to 
10 require on the occurrence of an accident, a serious 
11 accident involving heavy monetary danage or fatality, to 
12 require the individuals in that accident employed by the 
13 railways to undergo a drug screen. 
14 There the question is also whether or not such 
15 a test, such a screen, upon the occurrence of an accident 
16 would violate the constitutional rights of those involved. 
17 I might add that CELC has filed an amicus brief 
18 in the Burnley matter. And, in fact, I intend to attend 
19 the argument next week to see how the arqument's received 
20 by the court. Obviously, we'll not have a ruling, a 
21 definitive ruling, until the court hands down its 
22 decision. 
23 There was just a third case reported about a 
24 week and a half ago in which the United States Supreme 
25 Court has granted review. Interestingly enough. this case, 
26 which is known as the Consolidated Railway case, involves 
27 a private sector drug screening prograM. Here it involved 
28 the testing of current er:1.ployees without prior approval 
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1 of the union bargaining during routine physical 
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2 examinations. In other words, there,. employees underwent 
3 on an established basis routine physicals, and they added 
4 in this case the drug screen as part of the physical. Ther 
5 already had been urine testing in that situation, 
6 The issue, unfortunately, in one sense, may turn 
7 on the question of whether or not it was a technical 
8 obliqation to notify the union first, rather than whether 
9 or not an employer has the broad or narrow right to ii'1pose 
10 such a test. 
11 But it is most significant, ~r. Chairman, that 
12 we have now for the first time in the history of the 
13 United States before the highest court of the land two 
14 cases which have been consolidated to be heard on 
15 November 2nd, a third case in which they're taking 
16 jurisdiction. And I think it is without doubt that we 
17 are going to hear for the first time in the history of 
18 this country how constitutional rights are viewed by the 
19 highest court of the land to be balanced with the issue of 
20 drug testing in the workplace. 
21 In California, we have yet to see a definitive 
22 ruling on the question of drug testing and the right of 
23 privacy. As you are intimately aware from vour legislation 
24 
25 
26l 27 
28 
the key issue in California is whether or not Article I, 
Section 1 of the California Constitution~ th~t is, the 
right of privacy of every individual in this State, permits 
drug testing in the workplace. 
One major case,in which our firm is co-counsel, 
------------------------------------------------------------------------~ 
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1 is the issue of whether or not an er:<.;)loyer, regardless 9 
2 of the safety-sensitive nature of a working position, has 
3 the right to require all applicants, as a condition of 
4 employment, to successfully pass a drug or alcohol urine 
5 screen. 
6 In fact, in that particular case, an injunction 
7 was issued by the Alameda County Court enjoining such 
8 testing by the company involved. He appealed that 
9 decision. 'l'he Court of Appeals has stayed in the injunc-· 
10 tion. And the appeals which were taken to the California 
11 Supreme Court to, in essence, reverse the stay and impose 
12 the injunction failed. And the test in~; is go inc; for\,Jard 
13 while the litiqation is pending. 
14 This is clearly the seminal case on applicant 
15 testing, not only here in California, but it is in the 
16 United States in the private sector. 
17 We are quite confident, notwithstanding that 
18 there's much litigation ahead of us -- and, in fact, one 
19 of your subsequent speakers is one of our adversary 
20 counsels -- counsel. But we are quite confident that when 
21 this ultimately goes before the California Supreme 
22 Court, that we will prevail. 
23 SENATOR SEYMOUR: Excuse me. Mr. Schachter, that 
24 specific case is? 
25 ~1P.. SCHACHTER· That involves the Times Hirror 
26 Matthe\<7 Bender Company in Oakland, California. 
27 
28 
SENATOR SEYMOUR· Thank you. 
l'W. SCEACETER: 1\nd there are three named 
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1 defendants, who at various stages of the applicant 10 
2 process, refused to undertake the test and, therefore, 
3 were not employed (sic). 
4 And I believe John True, who is going to be 
5 testi ing before you later on, is one of the plaintiffs' 
6 counsel. And obviously, you mav wish to ask some 
7 questions of him. 
8 SENATOR SEYHOUR~ Very good. 
9 MR. SCiiACHTER: \•Jhat we have seen, Hr. Chairman, 
10 are uniform court rulings in the nation and even 
11 throughout our State and many other states that reasonable 
12 suspicion testing is lawful. And I think that there is 
13 little question that the Legislature needs to address on 
14 that issue alone. It may be that in future legislation, 
15 you would consider that you might want to reaffirm the 
16 uniformity of such an approach if legislation is 
17 proposed. 
18 But that issue is fairly well resolved. The 
19 most controversial issue is the issue which is 
20 characterized most commonly in the media as the question 
21 of random testing. Random testing I'll use in the sense 
22 that without notice, someone is basically told. without 
23 specific notice, of when their test is going to be taken, 
24 on short notice that they are to undergo a test, as 
25 distinct from ~andator7 testing, which means everybody is 
26 to be tested. ri'his \\TOUld be a ranuom selection. 
27 Clearly that kind of testing brings out the 
28 most sensitive ris_rht of privacy issues. And consequently, 
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1 there's been great wrestling, not only in the employer 
2 comnunity, but obviously with those concerned representing 
3 individual employees, about the proper balance. And 
4 they're very legitnate privacy issues as to how that ought 
5 to be resolved. 
6 There have been several Ninth Circuit Court 
7 rulings in the Federal Court that sits here in 
8 San Francisco that basically have held that union 
9 emplovees cannot disregard their collective bargaining 
10 grievance procedures and sue a company for violation 
11 of their constitutional rights where the union had in 
12 essence agreed to a drug testing program. 
13 Interesting enough, the courts have ruled that 
14 the question of drua testing is something that is 
15 negotiable and that it is not such a constitutional right 
16 that unions cannot give it away. 
17 But they really didn't reach the ultimate issue. 
18 ~Jhat thev said instead is if you have a complaint about 
19 the testing procedure, we're not going to deal with it on 
20 the constitutional grounds on California constitutional 
21 ric;rhts. 
22 We're saying you go through your grievance 
23 procedure, which is the Federal procedure that's given 
24 exclusive jurisdiction. So, it's been a more technical 
25 preclusion, if you will, of dealing with the issue on the 
26 merits. 
27 Both California decisions, by the way, upheld 
28 that there was not such a compelling constitutional right 
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1 as to disreaard the requirement to go through the 12 
2 collective bargaining procedure. 
3 There is, however, a clear trend in all of 
4 this, at least we believe there is. And that is that 
5 State and Federal courts,and particularly the Supreme 
6 Court of the United States is prepared to address -- are 
7 prepared to address the issue as they never have before. 
8 The San Francisco ordinance, as you know, 
9 requires reasonable cause and clear and present danger 
10 before testino; can be implemented. I've testified before 
11 your Coi'lffiittee in the past and have supported, and so has 
12 CELC supported your bills, because it does not require, 
13 I think, the extreme of reasonable cause and clear and 
14 ~resent danger. That is required by no constitutional 
15 standard and no case, and in our view, is a totally 
16 excessive reaction to le~itiFate concerns about drug 
17 testing, but is not re~uired to meet constitutional 
18 standards and is not appropriate in making sure that we 
19 Dreserve a safe and healthful working environ~ent. 
20 Because it is not just the right of privacy 
21 we're dealing here with, it is also right to a safe and a 
22 healthful working environment. 
23 1>Te have not seen, Hr. Chairman, a proliferation, 
24 as we originally feared, of the Maher bill. And I am very 
25 pleased and CELC is very pleased about that fact. And I 
26 think it's i~portant to you and your Committee to consider 
27 that fact in the years that have intervened since the 
28 initial legislation has been sponsored bv vou and your 
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1 Committee and considered J:w your Comr.ci ttee. 
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2 However, we continue to be concerned that such a 
3 proliferation mav take place, althoucrh it's not of imminent 
4 concern. And we are concerned that there be ap2ropriate 
5 safeguards in the testing, in the testing that is going 
6 forward. 
7 So, 1..vhile the Haher bill, vTe believe, is an 
8 excessive and an inappropriate response to the real issues 
9 in balancing due process with drug testing, we do believe 
10 that we need not be concerned with the immediate 
11 proliferation throughout the State, and that the courts 
12 really have taken charge in its own process -- in some 
13 '!vay slovJ and in some vrays not so slow --· to deal in a 
14 thoughtful way with the issues. 
15 CELC sun?orts requirements for test validity, 
16 including confirr.1atorv testing, preservation of samples 
17 with the right on the part of the person tested to do his 
18 or her own test. 
19 '·'le support clearly enunciated employer policies 
20 on confidentiality with respect to test results. Assuming 
21 test Validity, proper procedures, and confidentiality, 
22 CELC believes that em~)loyers should be able to do the 
23 following~ 
24 One, test all applicants. An employer has a 
25 right not to hire persons who use illegal substances. 
26 Tv'7o, test any employee when the employer has a 
27 reasonable sus:::::>icion of impairment due to substance 
28 abuse. 
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1 Three, test all employees in life·~ 14 
2 threatening, safety-sensitive positions. 
3 And, four, test persons \vho return to vvork 
4 after employee assistance progra:rr,.s designed to stop 
5 substance abuse in order to be assured that the person 
6 returns to the workplace truly substance free. 
7 CELC has in the past supported your bills. ~e 
8 believe they are moderate. ~e believe they are well-
9 balanced. And we believe they were very justified then 
10 and, in fact, if the Legislature would act on them as 
11 thev were proposed, t.tle believe they would be entirely 
12 appropriate now. 
13 However, the realities are, through the 
14 leqislative process, that there may be great controversy 
15 and differences of opinion about these very sensitive 
16 issues. And we do believe that the issues are being 
17 thoughtfully adjudicated through the courts. Ana at the 
18 present time, it is perhaps the preferable process to 
19 address the legal and constitutional issues that are 
20 involved. 
21 rTe certainly would v.:elcome legislative efforts 
22 to come up with the kind of legislation which you have 
23 proposed in the past. And we'll leave to your expertise 
24 and the expertise of your colleagues to determine whether 
25 or not it is feasible to accomplish such well-balanced 
26 legislation. 
27 In our skepticism and our experience in the 
28 past years, we have been aggressively involved in the 
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1 courts and we are hopeful that there will be an 15 
2 excellent balancing of what the various issues are in 
3 this State and in the country. 
4 ~~ may be wrong. And it may be, in your 
5 wisdom, that it is much more important for the Legislature 
6 to take the tact of proceeding and proceeding aggressively 
7 in this area. 
8 We clearly and strongly support any legislative 
9 efforts to assure that the proper due process safeguards 
10 as to the accuracy of the tests, the reliability of the 
11 tests, the chain of custody procedures. the due process 
12 procedures are in place. 
13 And I know that you and others in the Legislature 
14 have joined in efforts to accomplish this result. And 
15 we would urge you to continue that effort regardless of 
16 what the courts decide on the merits. 
17 No drug testing program would be acceptable 
18 unless those due process safeguards are there for the 
19 employees. 
20 I would close by saying that with respect to 
21 reasonable-suspicion testing, we believe that's been 
22 judicially established. With respect to applicant 
23 testing, accident testing, random testing, all these 
24 issues are before the courts and probably would be best 
25 resolved there. 
26 Unless we see a proliferation of varying 
27 statutes within our counties and within our municipalities, 
28 \ve vvould hope that 'vd th the Supreme Court and our State of 
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1 California fupreme Court that we will see definitive 16 
2 rulings ~ithin the next year or so. 
3 Thank you very nuch for letting me testify be::ore 
4 you today. 
5 SENATOR SEYHOUR: Thank you, !1r. Schachter. 
6 Yesterday, in Sacramento, we held a similar 
7 hearing to this one. And one who offered testimony was 
8 a Colonel V'allace representing the United States Department 
9 of Justice, offering testimony on the drug testing 
10 program for federal employees as requested by President 
11 Reagan in a presidential order, Executive Order. \'lould 
12 you care to coiTUT\ent on that? Do you know or are you 
13 familiar with the program? It was --· let me just comment 
14 myself. 
15 I thought it \\ras the most extensive program 
16 I have heard of, either public or private sector. 
17 MR. SCHACHTER; Uh-huh. 
18 SF'Nl'.'TOR SEYrmuR: I don 1 t know if you're 
19 familiar with it. 
20 ~"lR. s,CI-IACHTER: I arn generally familiar with it, 
21 ~~r. Chairman. There have been a host of other efforts in 
22 the public sector with respect to federal employees 
23 particularly, and also with respect to federal contractors 
24 in recent months, which I'm a little bit more intimately 
25 familiar, and I think involve the same ther'les. And I 1 d 
26 be happy to comment on it. 
27 There has been over the years a great deal of 
28 maturing, I believe, in the thinking of all responsible 
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2 make this comment, obviously I not only speak for those 
3 employers that we represent at CELC. but very frankly, the 
4 adversaries that I've faced in court and those that I've 
5 debated with over the last number of years on this issue, 
6 and I think that there's an understanding that has been 
7 gained. vvhile we still differ about whether or not and 
8 how drug testing should go fon·Iard, there is an understand! 'lg 
9 that there are honorable well-meaning people on both 
1o sides of the issue v'7ith legitimate concerns. P..nd while the 
11 feelings run verv strong, I think we have seen the 
12 government, the Federal Government particularly, grow 
13 in its appreciation, not only in the current administration 
14 but in earlier administrations over the years in its 
15 appreciation of the importance of due process safeguards 
16 and in the importance of not implementing drug testing 
17 merely to rid oneself of people's life styles and to 
18 retaliate aoainst those who have these problems, but to 
19 come forward with a program that balances identification 
20 of a drug problem through proper and fair procedures with 
21 a support to that program of rehabilitation. 
22 And I believe the program that you just heard 
23 about yesterday .:...._ and I knov.! that the program that's being 
24 considered now with federal contractors is a far crv from 
25 v.rhat happened in the earlier years. And l'Jhat it 
26 emphasizes is identification, not so that people will be 
27 set up for firing, but rather so that they can be 
28 identified as people who need rehabilitation. 
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1 And, yes, they'll be given the choice. The 18 
2 choice is: Either you rehabilitate yourself or you will 
3 be terninated. But they will be given a fair opportunity 
4 in which there will be confidentiality extended to their 
5 :r1edical records in order to qet themselves rehabilitated. 
6 And in our view, and I know it is your view 
7 in the past bills that you have sponsored, it is clearly 
8 for the purpose of identification and rehabilitation that 
9 drug testing has its greatest meaning. 
10 And I believe that the ef£orts that are now 
11 being made through the federal administrations that are 
12 involved as v,'ell as the agencies have a much greater 
13 ap0reciation, and the specific proposals, in fact, give 
14 substantial -Financial support to employee assistance and 
15 rehabilitation programs together with the testing that's 
16 going to oo forward. 
17 I applaud that and I arc~ sure that CELC "lr7ould 
18 applaud it. It has throughout the years. And any efforts, 
19 legislative efforts, to provide that kind of a balanced 
20 ap':)roach v.rould be enlightened and a very.. very positive 
21 development in the due process iml)lementation of druq 
22 testing throughout our workplace. 
23 SENATOR SEYl~OUR· Thank you very much 
24 r·1r. f~chachter. I know you're on a tight schedule, so 
25 we'll let ycu qo. Thanks for being with us. 
26 HR. SCHACHTER: Thank you very much. 
27 SENATOR SEYMOUR: Mr. Bob Taggert. I don't 
28 think he's arrived. Eow about John True? 
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1 HR. TRUE: Yes, sir. 
19 
2 SENATOR SEY!10UR: 1\11 right. 
3 rqe! 11 get the other half ~.vhile the first half 
4 is fresh in our wind. 
5 We could alr..ost set up a presidential debate 
6 between you t\·m fellovJS. 
7 MR. SCHACHTER~ You wouldn't get through on time. 
8 (Laughter.) 
9 SENA.TOP. SEYHOUR~ I • m sure it would be much more 
10 interesting than the presidential debates we've been 
11 watching. 
12 (Laughter.) 
13 HR. TRUE: I know Vic Schachter. I've worked 
14 with Vic Schachter. 
15 Jvlr. Chairman, I've brought some :rnaterials with 
16 me --
17 SENATOR SEYHOUR: Right. 
18 MR. TRUE: --· 20 copies of them. 
19 SENATOR SEY~,10UR: Great. 
20 MR. TRUE: You can tell me vJhat to do vlith them. 
21 SENl\TOR fEYHOUR: The Sergeant over here vlill be 
22 happy to receive those, Mr. True, or over there right 
23 behind you. 
24 Thank you very much. I see ~1r. Taggert has just 
25 walked through the door, Mr. True. 
26 ~R. TRUE: Shall I yield to him? 
27 SENATOR SEYl'·10UR: ''!ell, I don't know \'llhat his 
28 time schedule is. 
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20 Are vou on a tight time schedule, Mr. Taggert? 
rm. TAC'l::ERT: I'm five minutes early. 
SENATOR SEYHOUR: Oh, I guess I'm early. Okay. 
4 If you vrouldn' t mind yielding, Hr. True 
5 J11R. TAr.;GERT: No, that's .c· Llne. I apologize for 
6 beina early. 
7 (Laughter.) 
8 SENATOR SFYr~OUR ~ No. l'ii'e 1 ve been running this 
9 train on time, which is a surprise. This is great. 
10 Thank you, Mr. True. 
11 HR. TRUE: This is a brief outline. 
12 SENATOR SEYMOUR~ That's a lot of work. 
13 f'\R. TRUE: Good afternoon, r~r. Chairman. Thank 
14 you cor permittina me on behalf of the Employment La~.v 
15 Center of the San Francisco Legal Aid Society and on 
16 behalf of the American Civil Liberties Union Foundation 
17 of Northern California to appear before you and to briefly 
18 comment on some of the recent developments in drug-testing 
19 litigation. 
20 I'd like to point out for the record that I have 
21 compiled and provided to the Committee t1i70 docurn.ents. One 
22 is a relatively lengthy article that I have written in 
23 collahorn.tion v.rith my colleacrue Ed Chen from the American 
24 Civil Liberties Union. It arises from our experiences as 
25 litigators in the field, and points out what we think to 
26 be some of the salient legal developments in the area. 
27 Knm,Jing that your Committee is busy and perhaps 
28 you won't have the time to dive right into such a lengthy 
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2 which really focuses on the most recent and the most --
3 what I consider to be the most important developments in 
4 this field. 
5 And it is to that I'm going to briefly turn and 
6 direct my comments to some of the cases that I have been 
7 involved in that I think may influence the way the law 
8 develops in this area. 
9 I got into the room just in time to hear, I 
10 suppose, most of ~llr. Schachter's remarks, and I want to 
11 say that I agree with much of what he says. This is a 
12 very delicate, difficult, troubling, and challenging area 
13 of the law, one in which legitimate privacy rights come 
14 into sharp and direct conflict with the legitimate rights 
15 of employers to assure that they have a safe, productive, 
16 and appropriate 't•!orkplace. 
17 I have been, myself and my office has been, 
18 active in a number of cases involving the rights of both 
19 current employees and applicants as those rights are 
20 affected by employer drug-testing plans. And I think 
21 there are going to be some interesting developments arising 
22 from those cases. 
23 One which I'd like to bring to your attention 
24 is a case in Contra Costa County called Price against 
25 Pacific Refining Company. In that case, our office,along 
26 with the American Civil Liberties Union, obtained a 
27 preliminary injunction against a broad, sweeping, across-
28 the-board employee testing program ir.1posed on employees 
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1 with no suspicion whatsoever that there was 22 
2 individual druc:r use among the er.ployees or, indeed, that 
3 there was even a drug problem at the refinery. 
4 The judge in the case found that the program was 
5 ill-conceived and inappropriate under the circumstances, 
6 and made a findinq that the plaintiffs Hould be likel'' 
7 to prevail on the merits, and enjoined the program 
8 accordingly. 
9 Subsequent to the injunction, the refinery 
10 redrafted and refined its testing program and returned to 
11 court with a motion to modify the injunction, pointing 
12 out that their new proqram would limit them to testing 
13 under much more narrow circumstances, particularly a 
14 reasonable, concrete suspicion based on identifiable 
15 factors that an individual v.?as impaired by drugs on the 
16 job. 
17 I think that the judges ruling as to modify the 
18 injunction and permit that sort of testing to ao forward 
19 is an indication of where the law might develop. 
20 Interestingly, in the almost two years that have 
21 followed since that modification, there has not been one 
22 occasion when an employee has been tested on a reasonable 
23 ::;uspicion basis. 
24 There were a number of legal theories in that 
25 case, which I think mav be of some interest, because they 
26 are very typical of the kinds of legal theories used by 
21 plaintiffs across the State in challenging drug testing 
28 programs. 
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2 a great deal about, I'm sure, is the rights guaranteed 
3 to all of us under Article I, Section 1 of the 
4 California Constitution. I won't go into it, because I'm 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
sure that you're well versed in it as is most everyone 
who's familiar with drug testina issues. 
In addition, in the Price case, there were claims 
of invasion of privacy under common law doctrines, 
intentional and negligent infliction of emotional 
distress, claims of violation of the California 
Confidentiality of Medical Information Act, and of the 
Business & Professions Code prohibitions against unfair 
or unlawful business practices. 
I am here to tell you that most of the legal 
theories in the complaint did not survive the demurrer 
16 process. The judge found that such things as the 
17 Confidentialitv of Medical Information Act were not 
18 appropriately applied to the workplace. And she granted 
19 the defendants' demurrer in that respect. 
20 '/!e may or may not revisit those issues on 
21 a~peal, but right now we have decided that the appropriate 
22 thing for adjudicating everyone's rights in that case is 
23 to proceed to trial as quickly as possible. And that's 
24 what we're doing. 
25 ~hat remains in the case is our Article I, 
26 Section 1 claim as v!ell as intentional and negligent 
27 infliction of emotional distress. 
28 There are a number of other cases, which I have 
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2 All of them are cases in which trial courts up and down 
3 the f>tate have entered injunctions against enployer 
4 testing prograrcts where current employees are tested 
5 without regard to individualized susoicion of drug 
6 impairnent or dru~' use. 
7 Let me just comment briefl:'l also on a couple 
8 of cases which have not involved preliminary injunctions, 
9 but which have involved damages. 
10 There have been two cases in California 
11 involving alle~ations of wrongful termination based on 
12 either a refusal to go along with drug testing or an 
13 alleged false positive in the testing program. 
14 The first, Luck against Southern Pacific, 
15 was tried to a jury, as I'm sure you know, last year. And 
16 a jury awarded in excess of $480,00 to a 'lrJom.an who was 
17 fired on account of her refusal to participate in a random 
18 across-the-board test -- test program. 
19 The judge, I am told -- this is not a case in 
I have personally been involved -- but I'm told that 
21 the judge instructed the jury that it would be proper for 
an employer to require mandatory across-the-board testing 
23 if there were a legitimate, bona ~ide safety interest on 
24 the of the employer. 
25 The jurv considered that and found that under 
26 these circumstances, in that case, there was no such 
27 sa consideration and awarded damages to the plaintiff. 
28 The case has been ap~ealed and I'm told that the appeal is 
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1 pending in the First District Court of Appeal. 
2 Another Southern Pacific case involving an 
3 individual who was -- who tested positive and was required 
4 to be rehabilitated in a residential facility. It was, 
5 so I am told by the lawyers for the plaintiff, settled 
6 for an amount which is confidential. 
7 Finally, there is an out-of-State case, but 
8 another important case in this area, of an individual 
9 employed and vms tested and found to be to have 
10 a substance in his system, and terminated; ·thereupon. sued 
11 his employer, and was av-rarded $150,000 for intentional 
12 infliction of emotional distress, even though the -- it 
13 was found that the test was accurate and that the 
14 individual indeed had a substance in his system. 
15 That case is called Kelley against Schlumberger 
16 Technology, and it's listed in my outline. 
17 Mr. Schachter commented on the preemption issue, 
18 and I wish to iust point out that I listed a couple of 
19 cases for the subco~mittee. I don't think that it is 
20 the case, however, that a court has squarely faced the 
21 issue of whether a union may indeed waive in behalf of 
22 those it represents the personal rights of privacy, which 
23 may or may not be found by the California Supreme Court 
24 to be applicable to drug testing. 
25 There have been some legal developments, but I 
26 don't believe that they amount to a finding or a square 
27 holding that unions may simply bargain away the 
28 individual, personal, intimate rights that we all have to 
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1 privacy. 
2 Let me just note very briefly that there have 
3 been more than a couple of injunctions granted by 
4 California courts involving public employees. Those are 
5 listed on page 4 of my outline. And at least 1n two 
6 cases, courts have found that there is reason to enjoin 
7 across-the-board testing of both employees and applicants. 
8 And let me turn now to the question of 
9 applicants for employment, :because I agree v.1ith 
10 Mr. Schactler that this is going to be a major development 
11 in California, and one in v.rhich I think your subcommittee 
12 \•70Uld be -- would find very fruitful to examine. 
13 There is a case pending in Alameda County 
14 Superior Court involving ap~licants for employments to such 
15 jobs as copy editor, legal writer, and so on to a legal 
16 publishing house, \vhich publishes treatises on 
17 California law, including, interestingly enough, 
18 California emnlovment lavl. 
19 The ap~licants were required,as a condition for 
20 be hired at their jobs, to submit to an extensive 
21 cal screen, including a questionnaire which asked 
22 them all kinds of questions about their ~ersonal health, 
23 the consumDtion of tobacco products, their consumption 
24 of alcohol, history of various kinds of health problems 
25 in their ly, and they were reouired to submit to 
26 screening for alcohol and for drugs. 
27 Several of those individuals were concerned that 
28 L such a procedure effectuated a substantial invasion of 
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2 American Civil Liberties Union, we were able to obtain 
3 a preliminary injunction. 
4 In entering the injunction, the judge indicated 
5 that he, like all of us, was deeply concerned about the 
6 problem of drugs in our society. But he felt very 
7 strongly that a draconian inquiry of this nature into 
8 the private lives on individual applicants for employment 
9 was inappropriate. 
10 In fact, he characterized the views of the 
11 main expert witness for the defense as scary, insofar as 
12 they included such ~echanisms of social control as testing 
13 children and families, testing all drivers of motor 
14 vehicles, testing employees across the board. 
15 And I'd just like to point out that we, as 
16 advocates for \<rorking people and for employees, feel very 
17 strongly that drugs are not something to be laughed at. 
18 vTe a.ce not in favor of legalizing drugs. \·''e are not in 
19 favor of -- we're not people who feel that the drug problem 
20 is not a serious and potentially very debilitating one. 
21 But we feel very strongly that the war against 
22 drugs cannot be won by doing v1ar on the Constitution or 
23 by sacrificing constitutional rights. 
24 Mr. Schachter has described to you the posture, 
25 the present posture, of the case involving the applicants 
26 to employment in the legal publishing house. And I agree 
27 with him that it will be the California Supreme Court 
28 undoubtedly who will -- which will decide the rights of 
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2 We are going forward vigorously to trial and 
3 expect, and we'll certainly attempt to get a permanent 
4 injunction against the practice. And I'm sure the case 
5 will be litigated in the appellate courts. 
6 There is one other applicant testins case 
7 of which I am aware. It's called Spangle against Norco, 
8 Inc., up in Shasta County Superior Court. I'm I've 
9 listed it on page 6 of my outline. It appears to be a 
10 case involving an admittedly erroneous test, one in which 
11 sam:;les, urine samples, were inadvertently switched. P.nd 
12 the case is proceeding. I understand there have been 
13 some settlement discussions, but right now it's pending 
14 for trial. 
15 We think that a great deal of effort and 
16 thought needs to be put into the possible leqislative 
17 solution of the drug testing dilemma. \Te think that it is 
18 important that any kind of legislation which addresses 
19 the issue take a very serious look at the problems faced 
20 by ap?licants for employment. 
21 I think that vrhi it is easy enough, relatively 
23 are currentlv on the job, asserting in an effective way 
24 the rights of applicants is very difficult. An applicant 
25 for employment rna~ never know the reason why he or she is 
26 denied employment, may not know anything about the results 
27 of a test performed either 'qith or sometimes even without 
28 the knm1ledge of the a::_Yplicant. 
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2 strongly suggest, should include guaranteeing that 
3 applicants have concrete rights to due process, including 
4 the right to split a sample and provide a sample to their 
5 own physician or testing facility, the rights to know the 
6 results of the test performed by the employer, the right 
7 to have some sort of an appeal or at least present 
8 mitigating evidence or circumstances, at least argue 
9 that there might be some mistake to some tribunal which 
10 can have some power or authority to reverse the 
11 employer's decision not to hire. 
12 Because there are many, many thousands of 
13 people who are adversely affected by erroneous or 
14 negligently administered drug tests in an environment 
15 in which we currently live with complete lack of 
16 regulation, who never know and are never going to be 
17 able to assert valuable rights that they have to gain 
18 employment in a society, in an economy v1here employment 
19 has become very important. 
20 That concludes my remarks. I'd be happy to 
21 answer any questions. 
22 SENATOR SEYMOUR: Thank you very much, Hr. True. 
23 I guess the question I have for you, I'd ask you at least 
24 if you have a differing response -- since you're wearing 
25 two hats today -·- feel free to answer tv1o different v:ays. 
26 One hat, you're representing an attorney, 
27 a very highly skilled attorney representing plaintiffs 
28 typically on drug-testing cases; the other hat you wear 
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2 So, if my question causes different responses 
3 wearing those two hats, please feel free to so state. 
4 P•y question is this: In vour opinion, legal 
5 I op , are there any conditions, any conditions at all, 
6 under which you believe drug testing of any kind is 
7 condoned for anv position, whether it's one position or 
8 more, any conditions, any positions, in vvhich you think 
9 drua testing legally can be conducted? 
10 ti!R. TRUE: As a matter of fact, Senator Seymour, 
11 I do feel that there is at least one circumstance under 
12 Hhich testing of an emplovee ';vould be appropriate. 
13 And I appreciate your suggestion that I rnav 
14 delineate my position from that of the American Civil 
15 Liberties Union. 
16 I think I agree with the ACLU on practically 
17 everything that they stand for, but on the other hand, I 
18 -find self the some"ll'lhat uncomfortable position of 
19 acrree with Vic Schachter on something as well. 
20 Ee pointed out, as one of his four planks, so to 
21 in his drug-testing latform, that an individual 
22 return from an em:_Jloyee assistance prosram to 
23 employment should be an individual that an employer has 
24 the r to test. I agree with that. I think that an 
25 ind 1 who, through "'hatever circurnstances, has gone 
26 throuoh an employer-·provided employee assistance program. 
27 has admitted to a substance abuse problem, and is returning 
28 to work, having faced that problem, has got to understand 
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2 to random, unannounced testing. 
3 If I were an employer, I \vould demand that of 
4 such an employee, and I would feel it entirely 
5 appropriate. 
6 The phenomenon of denial of substance abusers 
7 is certainly a real one. And I think that an employer who 
8 has put out the bucks, so to speak, for an employee 
9 assistance program, is entitled to ensure that the 
10 results of it are followed through on. 
11 I don't agree with the other three assertions 
12 that Mr. Schachter made. I don't agree, for instance, 
13 that employee assistance programs should be front-loaded 
14 by means of random mandatory drug testing so as to find 
15 out if there are people about whom there's no 
16 individualized suspicion. 
17 I don' t agree that even ·-- and I admit that this 
18 is a difficult question -·- but I don't agree that in the 
19 reasonable suspicion circumstance, drug testing makes any 
20 sense. It does not ansv.rer the question that an employer, 
21 who has a reasonable suspicion of drug use, needs to 
22 know. 
23 It does not say: Is this employee or is he not 
24 impaired as of this moment on the job? It says simply 
25 that at some point in the past, the employee had a 
26 substance in his body, which is now producing metabolites, 
27 which themselves do not cause -- have any psychoactive 
28 effect or cause any impairment. 
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1 Now, those are very difficult questions 
2 brought on us by the advances in technology that we have 
3 been enjoying. Perhaps in the future, there will be 
4 technology which will be able to make those scientific 
5 determinations. But as of now, I don't believe·that they 
6 are appropriately made. 
7 SENATOR SEYMOUR· Next question I would have, 
8 Nlr. True, are there any conditions -~~· let me rephrase the 
9 question. 
10 Do you believe there's a place for preemployment 
11 screening in the areas of highly sensitive or highly 
12 dangerous positions endangerin0 the public at large? 
13 To be More specific: air controllers, nuclear 
14 some nuclear plant workers, railroad train engineers? 
15 Y·Je' ll stop at those three categories. 
16 ~m. TRUE~ I get the drift of vour question. 
17 I think it's a difficult one. 
18 probler:1 vd th preemployMent screening is that, 
19 acs,a , it is a measur device which is inappropriate to 
20 the measurements that need to be taken. I think, although, 
21 I \''ould point out ally, that the law here is 
22 rmch, much more undevelot:)ed than it is in the area of 
23 e11 rights, but it is to be determined, I am 
24 certain, the courts and possibly by legislatures, that 
25 employers do have the right to make inquiries about the 
26 backgrounds of those applying to them for jobs. Although 
27 I think it is possible, certainly, that some of the 
28 overreaching inquiries, such as use of tobacco products, 
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1 engage in private activities which are perfectly 
2 lawful although I think maybe some of those are going 
3 a little bit too far and overreaching, it's clear that an 
4 employer is going to have to be able to make enough 
5 inquiries about an applicant v.1ho, after all, is unknown 
6 to that employer, so that the employer can assure that the 
7 applicant is suitable for the job, it is not going to 
8 ultimately endaP-ger the employer's property, other 
9 employees, or the public. 
10 Now, my problem is that even in the instance of 
11 an air traffic controller or a nuclear power plant vmrker, 
12 a drug test doesn't add anything to the employer's 
13 knowledge gained in the application process. 
14 It probably would tell an employer, if an employe~ 
15 tested -- an applicant tested positive, that the 
16 applicant is of a fairly low IQ, but it does not --- the 
17 absence of a positive test does not materially add to the 
18 employer's knm.vledge. A.nd in addition, what it really 
19 is -- and I think people who are honest about this 
20 recognize -- it's a deterrent. It means that word gets 
21 out that if you're going to, you know, go to work for 
22 Times Mirror Company or whatever company, you're going to 
23 be tested. And it is a deterrent. 
24 As a deterrent, I think it is of questionable 
25 social value. Ne could deter a lot of bad thinas in our 
26 society. For instance, if we were to go house to house 
27 and inspect people's private domain, we certainly would 
28 find a lot of contraband and stop a lot of people from 
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2 But our fore decided a long time ago 
3 that that was inan?ropriate governmental behavior. 
4 SF.NATOR SEYYfOUR ~ That leads me to another 
5 question. The Maher ordinance here in San Francisco, 
6 which is ~art of a condition for testing re~uires a 
7 clear and present danger. 
8 Tell me how that would apply, in your opinion, 
9 to a situation, in which we had a defense contractor or 
10 a contractor building the -- responsible for very 
11 crucial and critical elements in the next space shot? 
12 ~1\R. TRUE: ~~11, clear and present danger is, 
13 as far as I understand it, a tern of art, and has a 
14 particular legal application, irrespective of vJhether 
15 in the ordinance it v·:as meant to have that ~)art.icular legal 
16 anplication. I think your question is: Is there any way 
17 to draw a briaht line around the possibly dangerous 
18 ztct 1. of an emp ? 
19 There is a case down in the State of Texas in 
20 which that very question that you've just asked was 
21 addressed the judge. In Jennings against :'1inco 
22 Technology, a Texas 1 court jud9e that assernblylin 
23 workers in a plant s and ~erforrning 
24 apparently very delicate, minute ODerations on an 
25 assemblyline vith silicon wafers and that sort of thing 
26 could be negligent through irr1pairrnent in such a way as to 
21 getting some grease or hair or some foreign substance on 
28 the silicon wafer upon which they vJere working and, 
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2 which could possibly be fatal to the person wearing the 
3 device. 
4 'l'o me, although I think that represents a 
5 laudable concern about accuracy and carefulness at work, 
6 it's simply taking the matter too far. Any one of us in 
7 almost anything \·;re do, indeed, Hrs. Luck at Southern 
8 Pacific, could conceivably, through some contrived 
9 set of circumstances, do something vlhich in some way down 
10 the line endanger others. 
11 And I think that legislators and judges as well 
12 have to be very careful about not stringing out these 
13 hypothetical possibilities to the point where they become 
14 meaningless. 
15 SENATOR SEYNOUR: Very good. \<1ell, thank you 
16 very much for your time and your testimony, r·1r. True. 
17 ~1R. TRUE~ Thank you, Senator Seymour. 
18 SENATOR SEYHOUR: ]l_t this moment, vJe vdll take 
19 a seven-minute break, according to that clock, and vJe'll 
20 reconvene at three o'clock. 
21 (Thereupon a brief recess was taken.) 
22 SENATOR SEYHOUR: He'll reconvene. Our next 
23 '''i tness will be Hr. Bob Taggert, Director of Public 
24 Relations for Southern Pacific Transportation Company. 
25 ~1R. TAGGERT~ Thank you, Senator. For the 
26 record, my title is Vice President for Public Affairs 
27 for the Southern Pacific Transportation Company. 
28 Let me give just an update, if I might, on the 
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1 testing program and the results of the testing 
2 program that we initiated -·- the urinalysis portion of 
3 the program, at least -- that was initiated in August of 
4 1984 at Southern Pacific. 
5 Being a railroad, we're stretched all over the 
6 country. Southern Pacific currently operates in 15 
7 states, and "'7 e have a little more than 26,000 em]?loyees. 
8 Our testing is based on our definition of 
9 reasonable suspicion. And that is not now a well-de~ined 
10 term in the legal co:r:mmni ty, but ·we define reasonable 
11 suspicion as any conduct that results in a human error 
12 type of accident or We don't judge the severity 
13 of the incident or the accident. It could be very minor~ 
14 it could be very major, it was caused by a human 
15 factor as opposed to a mechanical ~ailure of some sort. 
16 We began our testing program in August, 1984, 
17 and we have from then until now conducted over 20,000 
18 test . More than half of se tests are retests of 
19 individuals who have through rehabilitation and 
21 probationary return to work following rehab, and are 
22 subjected to mul and unannounced tests. 
23 I might say, too, that of the total nurtber of 
25 suspicion definition, less than five ?ercent of those 
26 tests were triggered observation of behavior,which, 
28 to believe that the individual was intoxicated with drugs 
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1 or alcohol or otherwise impaired. Over 95 percent 
2 of the cases are individuals who walked, talked, and 
3 acted just as normal as any other '·mrker did on the job. 
4 The three factors that we have determined 
5 through the years of preventive testing is that, number 
6 one, drug testing does indeed reduce drug use on the 
7 job and does act as a deterrent to drug use on the job. 
8 Be that good or bad, it nevertheless is a deterrent. 
9 The first month that "iHe conducted drug testing, 
10 urinalysis drug testing in August of 1984, in that month, 
11 over 22 percent of those tested under our criteria tested 
12 positive to the presence of drugs. There has been a 
13 precipitous decline in the failure rate from that time, 
14 and at the same time, there's been a marked increase in 
15 the number of individuals tested. Yet, even with the 
16 tremendous increase in the number tested, the decline has 
17 dropped riqht off the edqe of the cliff. So that 
18 presently, we are getting about five, 5.4, 5.5 percent 
19 on a three-state basis of the total of those tested 
20 who test positive for drugs. 
21 That does indicate to us that the fact that there 
22 is testing, does indeed act as a very powerful deterrent 
23 to drug use on the job. 
24 Drug use or drug testing, I should say~ also 
25 has resulted, v.re feel, in a dramatic decline in 
26 accidents on the job. 
27 In 1983, the last year prior to testing, we 
28 averaged 15.5 injuries per 200,000 man/hours worked 
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2 down each and every year since we initiated testing to 
3 198 7, the last full calendar year. It \vent from. 15. 5 
4 down to 6.7 injuries per 200,000 man/hours. 
5 And this year, for the first six months of 
6 1988, it has dropped even further to 5.8 injuries per 
7 200,000 man/hours worked. So, I g-ive you the data 
8 based upon man/hours worked to take care of the fact 
9 that there is, of course, rises and declines in the 
10 total number of employees. 
11 We find also that, as a result of testing, 
12 personal injuries have been reduced. In 1983, the last 
13 full vear before testing was initiated, we had 2.234 
14 Dersonal injuries throughout our system. 
15 In 1987, we had 784 personal injuries. And 
16 ln the first six months of 1988, we had 322 ~Jersonal 
17 iwjuries. 
18 Southern Pacific, in the last two years, has 
19 won the E. E. Harriman Av."ard (phonetic) , which is the 
20 rail industry's safety award, as a major railroad in the 
21 United States with the best safety record in the United 
22 States. 
23 Similar • we have seen a dramatic decline in 
24 accidents. In 1983, we had 911 human factor train 
25 ace s on our property. In 1987, this number was 
26 reduced to 135. 
27 Now, there have been no other significant 
28 events which have taken place that we have been able to 
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2 in personal injuries and in accidents other than the fact 
3 that we have initiated a comprehensive drug testing 
4 program. 
5 As you know, we are a regulated industry, 
6 regulated by the Department of Transportation through the 
7 Federal Railroad Administration. And we are required to 
8 test our employees for drug use under certain circumstances 
9 Southern Pacific's ?rogram goes far beyond 
10 the Federal minimum regulations. But you should know, 
11 too, that those regulations are presently under review 
12 and, as a matter of fact, early next month, November, 
13 the U.S. Supreme Court will hear oral arguments on the 
14 constitutionality of the Federal Railroad Administration's 
15 drug testing regulations. 
16 A cowment was made about impairment earlier on. 
17 And I vlould like to say just a fevJ words regarding 
18 impairment. ~rJe have taken the view that impairment is 
19 really not a criteria that should be attached to drug 
20 testing. 
21 Number one, impairment won't show in most 
22 instances on an individual case-by-case basis. But now, 
23 since testina has become a major issue in this country, 
24 there has been a v:ealth of scientific data which has been 
25 collected regarding the effects of drug use on the job. 
26 And it is found to be that a drug user is ~uch 
27 more likely to be involved in an accident on the job. 
28 He's much more likely to be injured on the job. He's 
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2 tir-te than a nonuser. Ee' s going to receive sickness 
3 benefits many times of those of a nondrug user will 
4 receive. 
5 The productivity and quality of his work will be 
6 reduced somewhat, although that's difficult to quantify. 
7 But he will be involved in many more grievance procedures 
8 and other v'Jotkrnen' s Compensation rc1atters, and is much 
9 more likely to be a dishonest employee, just to steal 
10 because he has a habit to support. 
11 I submit that those f'actors alone are more than 
12 ample justification for --· at least in the private sector -
13 for an employer to establish rules and regulations which 
14 ar1solutely prohibit drug use at all, impairment not being 
15 really the criteria that should be -~ that should be 
16 involved. 
17 I think, also, I was -- I was pleased to hear 
18 Mr. True say that he would su~port drug testing on a 
19 rando~ and unannounced basis for an individual who had 
20 gone through rehabilitation and returned to work on a 
21 ionary status. T•7e do require that of our employees. 
22 It is very significant that in San Franc sco, that's 
23 impossible under the San Francisco ordinance, which 
24 prohibits that type of testing under any circumstances, 
25 which seems to me to throw a cloud and a wet blanket on 
26 an employer v·Tho, in good faith, \tl7ants to rehabilitate an 
27 employee. And I think he has a reasonable right to 
28 expect that employee to subject himself or herself to 
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2 On the Federal level. the major departments in 
3 the Federal Government are in the process now of setting 
4 up their drug testing programs. Each department has its 
5 own program, but each department also does call for 
6 random testing under certain circumstances. 
7 The DepartMent of Transportation is presently 
8 testing about 1500 of their employees each month. There 
9 is an injunction, however, in effect on the random testing 
10 aspect of the Department of Transportation's program, 
11 which should be cleared by the u.s. Supreme Court 
12 decision fairly soon. 
13 17 percent of the total number of Federal 
14 employees today would be subject to random testing under 
15 the various Federal programs should the Supreme Court 
16 rule that random testing, under certain circumstances, 
17 is appropriate. 
18 And, as a matter of fact, the u.s. Department 
19 of Defense has in their plan, their testing plan. a 
20 requirement that all defense contractors have a plan which 
21 will guarantee a drug-free workplace. So, some of these 
22 plans go far beyond the boundaries of the Federal agencies. 
23 I might say that the Department of Defense -~ 
24 as a matter of fact, we're talking about a million and a 
25 half civilian employees in that department. And of those, 
26 150,000 of those employees would be subject to random 
27 testin<J. 
28 Host of the Federal regulations on random 
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2 public sa fet;r criteria, and as !~.r. True accurately 
3 pointed out, in the case of Barbara Luck vs. Southern 
4 racific, which is a local case here, the court did find 
5 that random testing,per se, does not violate the 
6 Constitution, the protections of the California 
7 Constitution, but indeed random testing is appropriate 
8 under certain circumstances, public safety being one of 
9 those circumstances. 
10 And, as a matter of fact, the railroad industry 
11 falls within public safety aspects. The court did find, 
12 however, that Barbara Luck's particular job did not fall 
13 within the safety-sensitive category and, therefore, 
14 testing of Barbara Luck under random circumstances was 
15 not appropriate. 
16 The omnibus drug testin~; bill, r.vhich was just 
17 nassed by the Congress, originally did contain provisions 
18 for testing of transportation industry employees -- rail, 
19 n.ir, and bus and truck employees. The provision was 
20 dropped at the last minute, because of some technical 
21 problems between the House version and the Senate version. 
22 And the omnibus bill does not contain mandatory random 
23 testing for transportation employees. 
24 ~'!e have l":•een ---- we feel that our testing 
25 program has Leen effective. ~·Je feel that it has ···· it hn.s 
26 done what was intended to do, and that is to reduce drug 
27 use on the job, reduce accidents, and reduce injuries. 
28 And the question seerrs to us, as it, of course, 
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2 certainly testing is an intrusion. Nithout question it 1 s 
3 an intrusion. But based upon the problem that we face 
4 in society today, based upon the proven results of drug 
5 testing when it comes to safety and other aspects, what 
6 is an acceptable degree of intrusion with respect to the 
7 dilemma in which you find yourself perched upon? 
8 I'd be pleased to answer any questions that 
9 you might have. 
10 SENl\.TOR SEY~10UR' Thank you, f1r. Taggert. 
11 The question I vmuld have is in the last two 
12 years, has Southern Pacific in its drug testing programs 
13 changed any of its policies, any of its testing procedures 
14 as it might relate to the quality of tests, changed any 
15 benefits relative to employee assistance programs, 
16 rehabilitation, or have you held to the policies and 
17 testing program that you had in place tvm years ago? 
18 ~~R. T1\GGERT: Pretty much to "IHha t we had in 
19 place tvm years ago or even three years ago. Pe did have 
20 one instance in which over a two-·day period, we did some 
21 random testing and that's from which the Barbara Luck 
22 case evolved. That was --- was stopped. 
23 The rehabilitation program has been consistent 
24 throughout the -- throughout the history of our testing 
25 and that is that any employee ···- any employee testing 
26 positive is given an option of leaving our employ or 
27 submitting himself or herself to rehabilitation. Upon 
28 successful completion of the rehabilitation program and 
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2 representative, the -- that individual is returned to 
3 work on a probationary status. The individual must agree 
4 to random unannounced testing for a two-year period of 
5 time. And if. after two years! it is determined by the 
6 El\P officer and the medical officer that the individual 
7 has stayed off of drugs and alcohol for that period of 
8 time, then he or she is returned to work on a fulltime, 
9 nonprobationary status. 
10 The results of that program have been 
11 relatively good statistically, and pretty much tracked 
12 with other industries. 
13 SE!JATOR SEYt1.0UR: ~·That do you mean, "relatively"-
14 MR. TAGGERT~ (Interjecting) l·:ell, I think 
15 it's disappointing to me that probably less than 40 
16 percent of the individuals who test positive for drugs 
17 and complete rehabilitation are able to stay off drugs 
18 for a period of two years. But those are the facts of 
19 life. 
20 And so, I find that personally disappointing, 
21 but from a medical statistical point of view 
22 SENATOR SEYMOUR: It's not bad. 
23 MR. TAG~ERT: it's not bad. 
24 SENATOR SE~·~oUR: Have you had any collective 
25 bargaining agreements in the last two years in which 
26 unions representing the employees attempted to negotiate 
27 anv aspects of the testing program or rehab or anything? 
28 I~R. TAGGERT: Oh, I think that issue is al'itlays 
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2 have steadfastly taken the position that drug testing is 
3 not a negotiable issue. It's a safety issue and falls 
4 within the exclusive province of management. And 'tile \-~Jill 
5 not put it on the bargaining table. 
6 SENATOR SEYP~OUR: I see. Well, thank vou very 
7 much. 
8 Obviously a very successful program. 
9 HR. TAGGERT: Thank you. 
10 SENATOR SEY11,10UR~ Our next witness is J1ike 
11 Anderson, Assistant State Director of the State 
12 Legislative Board, United Transportation Union. 
13 Mr. Anderson, thank you for being with us 
14 today. 
15 rm. ANDERSON~ Mr. Chairman, rn,y name is f~ike 
16 Jl,nderson, I'm the Assistant State Director, California 
17 Legislative Board of the United Transportation Union. 
18 ~·Je represent both rail and bus Ber.tbers of the 
19 State of California. 
20 ~~7i th rn.e is :',1r. Kenneth Rogers, \tJho is a trainman 
21 and a member of the ~rievance Co~mittee for one of our 
22 locals. In the past four years, he has had extensive 
23 experience dealing with the problehls that our members 
24 bring to us concerning drug testins. Our organization 
25 continues to strive for a safe place to work for all of 
26 our members. 
27 r·.re certainly do not condone the use of any 
28 form of chenical substance by employees while on duty that 
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1 will negatively affect their job performance. 
2 Our members are professionals and they take 
3 pride in their ~;.,rork. ~1r. Chairman, our organization, as 
4 you probably know, is opposed to drug testing on 
5 constitutional arounds. _, 
6 'fu feel that this will be cleared up within the 
7 next couple of weeks as has been testified to in the last 
8 couple of days. 
9 Even though we are opposed, we would like to 
10 have the chance to work with your Committee and bring the 
11 problems that we, as ---- brought to us, work with your 
12 Committee, and to show you certain areas that maybe 
13 vou could deal with to protect the interests of the 
14 employees who are being tested. 
15 One of the biggest problems in this druq testing 
16 is the problem of stress, v.rhat it does to the employees. 
17 '7hen a person is brought to an incident, like on 
18 Southern Pacific, if there is an incident, they will be 
19 taken from the job or sometimes four or five hours after-
20 wards, taken to the hospital vrhere they are put in the 
21 emergency room with their friends and their neighbors. 
22 A nurse could come up to the receptionist and 
23 say, ··~lhat are these people here for?" 
24 And they say, Well, they're from the SP drug 
25 testing." 
26 You don't have to worry about finding a place to 
27 sit dovm, because all the mothers v.Jill grab their 
28 children and move altJay. No one knm·.rs from that time on if 
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2 with the feeling that man over there is a drug addict. 
3 I read about him in the paper causing all the accidents. 
4 Confidentiality, then, is just destroyed. If 
5 you do come back positive from your test, the 
6 confidentiality is also destroyed on account that everyone 
7 will know right away, well, Joe Blow tested positive. 
8 He's gone. 
9 v·:re also believe that this has v·.rorked ~·- drug 
10 testing has worked right into the form of discipline by 
11 the carriers. They have used this as a form of 
12 harassment. Not all incidents are treated the same. 
13 If one member. one person, does one thing one 
14 day, he may or may not be tested. If he's tested, another 
15 guy does it the next day. he might not be tested. 
16 So we do not believe that it's -- it's an 
17 arbitrary decision made by the terminal officer. 
18 ~·7e believe that impairment is very important. 
19 Our job is ·'"- when we go to work, we are to be fit 
20 for duty, and that includes being free of drugs. We take 
21 our job seriously. ~·i7e knovJ that \,;hen we g·o to vTork, 
22 there is a one hundred almost 100 percent chance of 
23 getting on and off moving equipment, a freight train, 
24 locomotives, the like. 
25 Self--preservation is a prime factor, a motive 
26 for us to make sure that we are fit for duty. Our 
27 people do not want -- are not suicidal. They're there to 
28 make a living for their family, and they do not 
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2 when they are physically incapable. 
3 As I listened yesterday, when the colonel 
4 r1ade some threw some statistics out, we do have some 
5 reports that, if it would be ~ossible, I could share with 
6 your CoJTII11ittee later on in the week, next week, that 
7 certain statistics don't gibe with ones that we have, but 
8 I'll be glad to share them with you, and I 1 ll bring them 
9 to you in the next -- within the next week. 
10 SENATO~ SEYMOUR: Please do. 
11 HR. A.NDERSON: One of the things he brought up 
12 was that since the r·'\aryland Conrail accident, that there 
13 was 41, I believe, railroad incidences 1.•7here one member 
14 of the crew tested positive to a controlled substance. 
15 Now that controlled substance could be 
16 prescription medication. So, hov-.r nany of those, I'm not 
17 sure. Ee didn't say that any of these incidents were the 
18 t cause of drugs of a person \Jho -·· we have had 
19 m~nv cases where, say, I am on the head-end of a train, 
20 Ken is on the rear-end, on the caboose if we have one. 
21 If I do -- if I do something wrong on the 
22 head-end, I go too fast or go through a wrong signal, 
23 they can take us both in for a test. Therefore, if I 
24 I'm the one who's ~uil but I come back clean. Ken is 
25 over a mile, a mile and a half away in the caboose, he 
26 comes back dirt~, that goes down as a drug-related 
27 incident. 
28 So, therefore, the statistics do not always show 
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2 accidents. 
3 I think one of the ~ain problems that we're 
4 having is with the tests thems~lves, the reliability, 
5 '-'There these are taken, hmv long. V!e have now, as things 
6 stand, a person gives a test and he's still in service 
7 Eor up till the results come back if they are 
8 positive. If they are negative: he never hears. But 
9 he's still working around with that cloud over his head, 
10 not knowing whether the test is going to come back 
11 positive or negative. 
12 He could be clean as could be, but still we have 
13 had cases where false positives -- and one false positive 
14 is too many. It could destroy a life and a career. 
15 Say: for example, you were tested and it came 
16 back positive. You knew that you were clean. You did not 
17 drink. You did not take drugs. There was no way that 
18 sample should be positive. You have two choices. Go 
19 into a rehabilitation program set up by the company and 
20 get back to work as soon as possible. SP will probably 
21 get you back within 90 days. You go through a 30-day 
22 rehabilitation. Go to the outpatient. And in 90 days 
23 you're back to work. 
24 Or you can fight it. This could take one, two 
25 years out of your life. During this tine. once again, you 
26 are labeled as a drug user. You were fired off the 
27 railroad for using drugs. The stigma on your family, your 
28 kids.at school. 1'Your dad's a drug user.' Do you have the 
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economic power to stay out for two years? Do you have 
the money it takes to fight this type of a battle 
through the -·- having resamples, expert testimony; the 
economic forces just are 100 percent against you. 
~e've had people ca~itulate, tell roe personally, 
"I know I'm clean. But I can't. I've got a house 
payment. I got three kids. \>Jhat am I supposed to do? 
I got -- I'm living from payday to payday right now. How 
am I going to stay out there for ·two more :tears? You 
can't even guarantee me I'll win then." 
And certainly I can't. You never know what's 
going to happen, and it could rule one way or the other. 
And, as Ken will get into in a minute, the chances of 
proving yourself -- when you take your test, you are 
guilty until you prove yourself innocent. I don't think 
that is the due process that we've been looking for in 
this country. And I think it's one thing that we should 
be considering, along with all these other drug testing 
positions. 
As far as Hr. Taggert's testimony -· and I' Til 
sure that when the word leaves his office, that's the way 
it is. However, by the time it gets down, filters down 
the long, tall totem pole, down to the field officers, 
somet s that changes. 
These are some of the things. .~'Ie will not 
bring them up today. But I \'Till be -- promise to 1.mrk 
vrith your Committee, even thouah we're opposed to drug 
test , but \ve think you should have all the inforqation 
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2 things for the ~· for our members. I echo many of the 
3 things that the ACLU attorney said today. There's no use 
4 going over them again. 
5 But as you probably can figure out, that we 
6 fully support those provisions. 
7 I'll turn it over to Ken nowr and he will give 
8 you a little brief survey over what we consider very 
9 important on the quality control items of the testing. 
10 SEN!, TOR SEYHOUR • Before vle proceed to Ken, 
11 Mr. Anderson, I have a question for you. 
12 1'1.R. PJ:JDERSON 7 Certainly. 
13 SENATOR SEYMOUR: The same question that I asked 
14 .Hr. True. 
15 Are there any conditions on any jobs under which 
16 your union would support a drug-testing program? 
17 .~m. ANDERSON: ~'Jell, v·le consider right now that 
18 it's unconstitutional. Therefore, we'll have a better 
19 idea after next week, when the constitutionality is 
20 figured out, then we'll be able-- and the U.S. Congress, 
21 as I've not seen the bills that the FPJ\ is proposing, at 
22 that time, maybe we'd have -- be able to have more to say 
23 about it. 
24 But at this time, we can't say where we should 
25 think anyone shoulci be tested at this time of our members. 
26 SENATOR SEY!10UR: Thank you, sir. Yes, sir. 
27 M.R. ROGERS~ Hy name is Kenneth Rogers. And 
28 strangely, without my volunteering to do it, I've fallen 
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1 heir to quite a number of defense cases and Rule G 
2 allegations on the particular railroad and on other 
3 railroads that I'm associated with through the United 
4 ~ransportation Union. 
5 I'm impressed with --perhaps as much as you 
6 are, ;'1r. Chairman ····- vrith the degree of maturation that 
7 has occurred over the last four years, particularly over 
8 the last two years it.Tith the point of view and the expert 
9 input and the recognition of that input into what may 
10 eventually either become court case law or legislative 
11 law. 
12 In the initial stages of both your and 
13 r1r. Klehs' participation in this drug-testing arena, there 
14 was a lot left to be desired. One of the key phrases 
15 currently being mentioned and which I confront almost on 
16 a 1,veek basis is the phrase called, 'due process." l\ 
17 lot of 1 service, hopefully a lot of words will be 
18 lt whatever decisions are rendered in whatever 
19 forums to enunciate clearly exactly what that means 
20 in terms of drug testing. 
21 My major problem in defense of railroad workers 
22 accused of Rule r. violations is that the nrovision for 
23 due process is extremely attenuated, limited, or 
24 stent. Perhaps in agreements, railroad labor law, 
25 or the Railroad Labor Act there is language generally 
26 coached (sic) addressing that issue and subject, but in 
27 practice, the railroad managenents almost unilateral!~(, 
28 without exception, keep defendant employees from having 
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2 ?resented with the awkward ?OSition of being presented, 
3 ?erhaps only at a hearing and not before, with a 
4 laboratory report that most people that are in the 
5 collective bargaining adjudication procedure have no 
6 familiarity with. 
7 They're not giving it to them before the 
8 hearing, so it can be scrutinized by independent 
9 consultants who know what they're looking for. It's like 
10 reading a life insurance policy. A life insurance 
11 salesman knows clearly the contract language he needs to 
12 search for for merit. \·Jhereas, on these reports, it's 
13 hard for a local griever to know what to look for in order 
14 to defense a case or even see the most fundanental 
15 problem with a report. 
16 Hare inportantly, we are given no raw data from 
17 the laboratories, no quality control reports, no evidence 
18 of proficiency testing, no quality assurance proof that 
19 that is, in fact, occurring, or that it is even in place 
20 to be implemented in the laboratories that are being used 
21 by railroad em:;loyers. 
22 VJe are given testiP"'ony by nonquali fied, 
23 nonexpert, nonfamiliar management employees that say that 
24 all is being done and all is well, and you should take it 
25 at face value. I can't take it at face value. 
26 On every successfully challenged case, and 
27 we've had maybe tvJO or three, major problems have 
28 developed and been elucidated at those hearings. But it 
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1 has been throu~h quirk, a luck-out, somebody divulging 
2 something that clearly would never have been divulged. 
3 Br ing an ex?ert witness from the lab has become one of 
4 the major problems. 
5 And if you're successful in doing it, you're in 
6 a minority instead of the majority. ~'Jhere ny emphasis 
7 is is access to raw materials for independent consultant 
8 analysis, which oftentimes can divulge the source of the 
9 \<Trongful alleqation against the employee. Lack of access 
10 to that information is totally the antithesis of 
11 due process. 
12 If we're going to legislate or if we're going 
13 to litiaate law in this area, let's not lip service due 
14 process and then in practice totally eliminate it. 
15 Retesting of the original sample from the original bottle, 
16 that's the primary first step;any consultant will tell 
17 vou that. The problem is getting the sample. 
18 Current railroad employers have no obligation 
19 from their pers;_:)ective to give you access to it. And 
tnen, if they do. they say it will be retested at our 
21 lab, not your lab. And then, if that test does show the 
22 presence of the alleged conpound, then other testing 
23 
24 
25 
26 
27 
28 
becomes necessarv. It's a flow-chart mechanism here. 
Now, you have to go to perhaps rule out 
contamination. There are certain tests that can rule out 
and attack that subject area. Perhaps you should also 
rule out that it may not be your sam~)le at all. 
Mislabeling, labels ~alling off, being erroneously 
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2 a known fact in this industry. 
3 Serological testing on urine samples is a known 
4 -:act also. It's very expensive. Fe had a member pay 
5 almost $1500 to have the serological work in the 
6 strange circumstances where he had subpoena rights so he 
7 could get his hands on the sample. 
8 Ninety-nine percent of the cases will never get 
9 to the sample to do that testing. Even though the 
10 employee and the employees that I address, I frankly tell 
11 them up front, vJhat we're looking at is one to tr.,lo years 
12 to get it to an arbitrator. No guarantee that the 
13 arbitrator will know what in the hell we're talking 
14 about, no way to get ahold of the sample to retest it. 
15 Due process is my eD;::>hasis, r1r. Chairman, and 
16 it cannot be lip~serviced. It has been fully, fully 
17 implicated (sic). 
18 Mr. Schrafner (sic) emphasized that. ACLU 
19 eMphasized that. Unilaterally, across the board, everybody 
20 lip-services it, but when you get into the arena I'm in, 
21 in the trenches, lip service doesn•t do the job. 
22 Do you have an'( questions? I'd be more than 
23 willing to answer them. 
24 SENATOR SEYMOUR: \'Tell, Hr. Rogers, I don't have 
25 a question, but I sure have a statement that's been 
26 welling up in me for a long tiDe. 
27 Here vle are t•11o years later on this subject. 
28 And I totally eDpathize with \•That you do. '.{ou' re getting 
PETERS SHORTHAND REPORTING CORPORATION 
3336 BRADSHAW ROAD, SUITE 240 
SACRAMENTO, CALIFORNIA 95827 
1 
55 ripped off. Your members are srettinq ripped off. I 
2 totallv em1>athize, understand. 
3 Some employersc particular SI"',all employers 
4 who can 1 t afford the Southern Pacific type organization 
5 battery of attorneys to defend themselves~ totally 
6 svmpathetic with what 1 s going on. The sad thing is--
7 is that the boys at the top, whether it's you in the 
8 union or ,,rhether it's mana<;reJTlent on the other side, 
9 would rather, obviously, rather see this vhole thing 
10 determined in the courts, go through the lengthy process, 
11 than come to the table and ne<;rotiate a program that you 
12 out in the firin0 line can live with and have 9rotection 
13 for your members. 
14 And it is because it never happened up here 
15 that the courts are writing law in this field. The 
16 tions you want -- v1here was 'fOur organization v,rhen 
17 LTohan Klehs tried to move a quality of testing bill? 
18 I'll tell you. They were opposed, because vou 
19 see held the line that said I respect 
20 f1r. Anderson. This not meant to be demeaning in any way. 
21 held the 1 , "~"Te' ll beat this thing. There ~ .. mn' t 
22 be testina. And that way, we'll get the best for our 
23 members.·· 
24 Well, if you can, super. I doubt vou're going 
25 to do that. I think testing of some form or another is 
26 here todav. 1\nd the sooner, the sooner management and 
27 labor get to the bargaining table and we get some 
28 islation dm·m to, as I said in my opening statement, set 
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1 some ground rules to ensure the very things you're 
2 talking about ···- I listened to Hr. True here today. I 
3 asked him the question, 10 Now, are there any conditions 
4 under vvhich you think the preemployment screening vTould 
5 be okay?" 
6 And he cited them. ~-Jell, I~ 11 tell you what he 
7 cited. He cited 90 percent of v'hat \·.·as in rry bill, Senate 
8 Bill 1611 on preemployment screening. Protections. 
9 Confirmatory testing of the same sample. The employee 
10 gets to take that to '''hatever lab they v1ant to have it 
11 tested. Confidentiality. The right to retest. All kinds 
12 of protections. But, no, ··~'le'll beat 'em in the court." 
13 That wasn't our choice in the Legislature. That 
14 was your choice. Not your choice, Mr. Rogers' choice, 
15 not the guys out in the trenches that are paying the 
16 price. That was the hierarchy's choice. 
17 So, when you're ready, I'm ready. And when 
18 management is ready, I'm ready. But until you are, fight 
19 it out in the courts. That was your choice. 
20 Well, I certainly didn't --that's been boiling 
21 up in me for some time. 
22 '·1R. RO,~ERS: Can I rev1rite just one small 
23 SENATOR SEYMOUR: Oh, sure, go right ahead 
24 HR. ROGERS: -· .. - it's just a technicality. 
25 I think Mr. Taggert touched on this, even though 
26 it may have passed by. 
27 That particular railroad's current stature (sic) 
28 and the large majority of all other railroads are that it 
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2 testing. 
3 And they will not initiate or allow to be 
4 initiated drug testing negotiations of any form. 
5 SENATOR SEYfJlOUR: I predict, r1r. Anderson 
6 f1r. Rogers, I predict that wi t'-lin the next two years, 
7 zed labor will be beating down the doors of the 
8 Legislature seeking legislation to protect their meFlbers. 
9 •crhy? Because those decisions in court are going to go 
10 aaainst them. f1y question is where the hell you been? 
11 MR. ROGERS: Hhat \•Je 've been doing is spending 
12 hundreds of thousands on legal fees --
13 SENATOR SEYMOUR: That•s right. 
14 MR. ROGERS: Arguing major and minor issues 
15 to to aet it on the bargaining table. 
16 SENATOR SEY~OUR! nn the bargaining table. But, 
17 you see. you could have come to the Legislature ·-- maybe 
18 I have too rmch faith in the Legislature. I could be 
19 myself. But I tried to offer a chance. And ny 
20 Democratic cohort, cJohan Klehs, over in thP :trea of quali t:zr 
21 of testing, tried to offer an opportunitJ to come up with 
22 fair parameters, fair definitions, protections. But 
23 ne side really wanted to get serious about it. 
24 fo, here we sit. And the purpose of this hearing 
25 of course. is hey, let's take a look and see what's 
26 ha~pened in the last two vears. 
27 There's been maturation 1 as you said. :·:lr. Eogers, 
28 the last two years. reople are beginning to understand 
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2 the judicial system, which is what your guys and the 
3 management guys wanted to rely on, that's moving along, 
4 too. 
5 So you got what you wanted. 
6 !1R. n.OGERS: What I'm saying and vJhat my vJhole 
7 testimony's thrust is if. in fact, vle get to a 
8 legislative resolution to this -- and I'm not sure. ~e've 
9 heard testimony today that it should be perhaps the 
10 subject matter jurisdiction of the courts (sic). I don't 
11 know if there's misplaced faith in the courts on this. 
12 Perhaps what is being said and will be the 
13 resolution of these hearings is let the courts do whatever 
14 the courts are going to do, but don't get the 
15 legislative cart in front of the courtroom. 
16 SENATOR SEYFIDUR: And that's probably what will 
17 happen, Hr. Rogers. But let me tell you I think that is 
18 unconscionable. 
19 The Legislature 1 s supposed to write the laws 
20 and the courts are supposed to interpret them. But there 
21 isn't one law on the books that says anything, other than 
22 our Constitution, the constitutional rights that are 
23 challenged, that says anything about drug testing. 
24 Nothing. 
25 H? .. ROGERS: ~/'ell, it couldn't have been 
26 anticipated two years ago. 
27 SENATOR SE:Yf.~OUR: HOlt! uould you like to be an 
28 employee out there not represented by a union subject to 
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2 You want to talk about people getting ripped 
3 off. at least you've qot an organization to take vou 
4 through the grievance ~rocess. 78 percent of 
5 California's employees don't have that luxury . 
6 . 'lR.. ROGEES: In a certain sense. there's a 
7 false sense of security given to those 22 percent. 
8 SENATOR SEYHOURc I agree. 
9 MR. ROGERS: Prom the trenches, it's a long way 
10 up. 
11 SENATOR SEYF11.0UR: ~~r. lmderson, I didn't vrant to 
12 cut you off. If you want to respond a bit to what was 
13 welling up in me, and perhaps get a bit too emotional, 
14 feel free to go ahead. 
15 ~m. ANDERSON: That's quite all right, Senator. 
16 Thank vou very much. 
17 As 4r. Taggert said, SP will not negotiate this 
18 fact. Therefore, our next alternative was to the courts, 
19 s we do feel that this is unconstitutional. And 
20 that is, when vou do feel vou have a constitutional issue, 
's where you belong. right in the courts. 
22 As I said, even though we disasree with drug 
23 testina, as I said before, I'd be more than willing to 
24 br out the data that we have to you so that you can be 
25 aware of the nrohlerns that we have. Two years aqo, we 
26 didn't have -· "~de didn't know about half the problems we 
27 have today. 
28 This is a new field for all -·· I think for 
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2 SENATOR SEYJI.~OUR: ITr. Anderson, let me tell you, 
3 and I know you're not naive, and I know you're very 
4 experienced, and I hold you in high regard. 
5 Until organized labor is willing to support 
6 some legislation and until management, the large 
7 companies -~· the 50--some large err.ployers employing 
8 400,000 peo?le in this State that Vic Schachter 
9 represents ··- until they are \,·lilling to SU;Jj)Ort something, 
10 and we can find some ag·reement, there "ain't" going to be 
11 any legislation. because those two ~owerful special 
12 interests will kill it before it starts. 
13 rm. ANDERSON~ As I . ~ sa1a, v.re 'd be very ha:?PY 
14 to share with you our data and what we have to help you 
15 in drafting -- if vou're going to draft legislation. 
16 SENATOR SEYf~OUR • Okay. I really appreciate 
17 that. And I want to apologize to you. It could have been 
18 Schachter sitting here, Taggert, just got u~"J to the 
19 boiling··over point v1here I had to relieve mv =:rustration 
20 T guess over the last -~· I've been carrying lecrislation 
21 on this since '86, and I think I understand the politics 
22 o=: it very clearly, and I was frustrated in not being 
23 able to qet something done. It certainly was not meant 
24 in any v1ay, sha;_)e or form to demean your organization, 
25 you personally, or anything else. 
26 ~1R. ANDERSON; No problem, Senator. 
27 SE!JATOR SEY!10UR: Okay. Thank you very much 
28 for your testimony. 
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1 ~e're going to take a ten-minute recess, and 
2 ""e will hear from two of the testing firms. 
3 (Thereupon there was a recess taken.) 
4 SENATOR SEYMOUR· We'll reconvene the hearing 
5 and we'll hear from our last two witnesses. 
6 The first witness is Mr. Bob Fogerson, who is 
7 the Director of Quality 1\ssurance from the PharmChem 
8 Laboratories, IncorDorated. 
9 Thank vou for taking the time to be with us, 
10 Mr. Foqerson. 
11 ~t8.. rOGERSON 7. You're c;:ui te v . relcome, and I 
12 thank you, Mr. Chairman. 
13 As you say, I am the Director of 0uality 
14 l\ssurance at I'harnChen LalJoratories. \Je' re located just 
15 dm.;rn the road a bit here in ~1enlo I'ark. 
16 way of background? Phan'1Chem is, to the best 
17 of my knowledse, the oldest and largest independent 
18 labor a in the United States, and specializes 
19 exclusively in testing for drug abuse. 
20 The lab was founded in 1971, and in the 
since that tine. has testerl samples from 
22 literally manv hundreds of addiction treatment programs, 
23 
24 
25 
26 
27 
28 
from court probation , ;_'Jublic employers private 
s, much the gamut of organizations that do 
testing in the last 15 years or so. 
I must say that I am pleased to have another 
tunitv to discuss some of the issues that are 
lved in testinq for drugs of abuse with this 
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1 Comrni ttee. I vJas a bit shocked the other day and 
2 during this testircony to realize that it has been two 
3 years since I previously s:c1oke before the Committee. 
4 SENATOR SEYMOURr Time flies when you're having 
5 fun. 
6 MR. FOGERSON: I guess so. It's been a very 
7 busy tv-ro years in the field I suppose. That's why it 
8 didn't seem like that long. It certainly doesn't. 
9 r,rhat I want to do today,. if I can, is spend 
10 a little time describing some of what I think are the 
11 very significant developments that have occurred in the 
12 field over the last two years, and to try to get some 
13 sense of what the technical status is in the drug 
14 testing business today. 
15 SENATOR SEYHOUR: Good. 
16 MR. FOGERSON: I'll try not to repeat some of 
17 the points that have been raised by the previous 
18 witnesses. 
19 When I testified in 1986, there was a very 
20 widespread, almost a general fear that the laboratory 
21 technology that was in place wasn't going to be capable 
22 of the sort of accuracy that you would need to be able 
23 
24 
25 
26 
27 
28 
to embark on large-scale testing programs ·with confidence. 
And I vrould say from the testimony today, that 
has not entirely been dissipated. 
But going back to 1986, a lot of that grew out 
of a report that was published by the Journal of the 
American Medical Association in 1985. The report 
PETERS SHORTHAND REPORTING CORPORATION 
3336 BRADSHAW ROAD, SUITE 240 
SACRAMENTO, CALIFORNIA 95827 
63 
1 described a study that had been conducted by the 
2 1 Center for Disease Control. And they did the 
3 to assess laboratory accuracy. 
4 The performance of the labs that were tested 
5 1n that study really was pretty dismal. And, as a 
6 consequence, that report became taken very quickly as an 
7 indictment of biotechnology, per se. 
8 That interpretation of the report was never 
9 \.11arranted. It was a poor understanding of the study, but 
10 that interpretation became so common that in the end of 
11 1987, one of the authors of that report was moved to write 
12 another letter to the same journal trying to clarify what 
13 he felt the study demonstrated. That individual is a man 
14 named Dr. Joe Boone, and I think it's t·Jorthv.7hile quoting 
15 some parts of that letter clarifying the issues in his 
16 view. 
17 Dr. Boone states in 1987, in November, that: 
18 'The science on which drug testing 
19 rests is solid.,. 
lie then goes on to explain that reliability 
testing reauires not only the analytic procedure be 
22 teclmical sound, but also that sample collection, chain 
23 a custody, and reporting procedures are adequate to 
24 assure accuracy. 
25 His final conclusion was that if the science 
26 is applied proper , then, and I auote: 
27 
28 
"No analytic false positives 
should occur." 
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1 In the course of the last few years there's been 
2 an opportunity to develop a lot of evidence that that 
3 really does support that conclusion. 
4 I told the Committee in 1986, of one of our own 
5 programs, in which over a 15-month period, we had handled 
6 about 5400 test samples without producing a false positive 
7 test resulting from that group. That program didn't end 
8 in 1986, In fact, it continued on into early 1988. 
9 And by the end of the program, that 5r000 
10 samples had grown to 13,000, still with no false 
11 positive test results produced. 
12 Similarly, earlier this year, we were involved 
13 in preparing a legal brief for one of the cases, which 
14 one of the attorneys mentioned, the Von Raab case, 
15 that's going to be heard next week. 
16 And in the course of preparing that brief, I 
17 took the opportunity to look over the proficiency data 
18 that's been produced by all of the Department of Defense 
19 drug testing labs for a five~year period, from 1983 to 
20 1987. 
21 That program's much more extensive. And that 
22 program -- there were about 49,000 negative samples sent 
23 to those labs on a blind basis. And they didn't produce 
24 any false positive test results. That's over five years. 
25 A very impressive record. 
26 So, I think there's plenty of reason to believe, 
27 on the basis of that sort of experience, that drug 
28 testing really can be done with existing technology with 
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2 And I don't think it would be going too far 
3 to say that that really has become the consensus of the 
4 knm le scientific community. And there certainly 
5 are s 1dho dispute that, but, as exam~)les, in 
6 1987, the Finegan (phonetic) Corporation in San Jose 
7 sponsored a stud7, in which they surveyed 25 experts in 
8 ic laboratory procedures, and asked them how they 
9 lt about various types o£ drug testing that were being 
10 done in laboratories today. And specifically they wanted 
11 to know whether or not these results vvere legally 
12 defensible. 
13 There were two different combinations of 
14 tests that all of the experts surveyed agreed were fully 
15 de fens e, and that either of those combinations of 
16 , they felt, would be a hundered percent accurate. 
17 Orcranizations like the American Society of 
1a Cl 1 Pharmacology and Therapeutics. a very old, very 
19 eminent association of scientific professionals. in 1987, 
convened a consensus conference to discuss the issue of 
tes and came to much the same conclusion. 
22 So, I that the earlier statement that 
23 there really is a consensus in the scientific community 
l r one. 
25 l'.nother verv much related issue that v.ras in the 
26 forefront in 1986, at least in California, was the 
27 cruestion of certi ing laboratories. And several of 
28 witnesses earlier today have alluded to that. 
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1 The problem is this: If you grant that 
2 existing technology, when it's properly applied, can 
3 produce a reliable test result, you're still facing the 
4 question of how do you know,on a laboratory~by-laboratory 
5 basis, that your lab is capable of the proper application 
6 of that technology? 
7 \vell, there really wasn't, in 1986, any 
8 regulatory body addressing the special requirements 
9 of large scale programs doing drug testing in the 
10 workplace in California, in any other state that I know 
11 of, on a national level, anywhere. 
12 That situation has changed radically in two 
13 years. On the national level, there are currently two 
14 certification programs active, in place, and about to 
15 announce their first list of certified laboratories. 
16 One of them is administered by a Federal 
17 agency, the National Institute on Drug Abuse, a familiar 
18 organization usually referred to by the acronym NIDA, 
19 And the other is a private sector program. And 
20 it's operated in a joint project by two eminent 
21 professional organizations ·-- the College of American 
22 Pathologists, CAP, and the American Association for 
23 Clinical Chemistry. 
24 The programs are very similar to each other in 
25 the requirements that they've established for proper 
26 laboratory procedures. Both of them have established 
27 standards, and fairly detailed standards in many cases, 
28 for laboratory personnel and facilities, test procedures, 
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2 And I believe in vour packet of materials for these 
4 Labnratories, in order to attain and maintain 
5 certif ion, have to pass a continuing series of 
6 ?erformance tests. And I think laboratories that are 
7 certif by either or both of these programs should be 
8 capable of doing a good job at conducting an employment 
9 drug testing proaram. 
10 And this alone will go a long way toward some 
12 vo about how an employer, or union, or anybody else 
14 quality of the drug testing ,,Tork that's being done. 
15 The purpose of the certification programs is 
16 to e ish some minimum standards, so we know a little 
17 about what's being done at any certified laboratory. 
18 In addition to the two national programs, a 
19 number of states have already established their own 
certification systems. And these often draw very heavily 
on the same set of standards that you find in the NIDA 
23 FharmChem, for instance, is currently licensed 
24 ifical for employment drug testing in Nmv York, 
25 , Connecticut, Vermont, !~'aryland, Hinnesota, 
there are others pending. 
27 I guess this relates to your comment, as well, 
28 about the possibilitv oF passing legislation. Those 
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1 states have done that. They've passed requirements 
2 about being certified. They've passed requirements about 
3 certain procedural standards being established and 
4 followed. So, there's experience on a national level at 
5 passing legislation in this field. 
6 But with the establishment of these certification 
7 systems, I think the whole field of employment drug 
8 testing comes to a new level of maturity. At this point, 
9 not only have we discovered the technological 
10 requirements for doing these tests accurately, but we 
11 are beginning to devise institutions that will allow us to 
12 make sure that, in fact, in real life programs, they are 
13 done accurately. 
14 But, as I'm sure everybody's aware, these sorts 
15 of technical fields rarely remain static. And they 
16 probably shouldn't. Speaking as a quality assurance 
17 director, quality is always a moving target. And as we 
18 get better, our notions of how much better we can be 
19 are elevated accordingly, but a lot has happened in the 
20 last t'\vO years in that arena as well. 
21 As drug testing programs have developed and 
22 gone forward, there's been an explosion in all sorts of 
23 research efforts, efforts to address some of the problems 
24 and questions that people have developed in the course 
25 of assessing programs, efforts to develop new 
26 instruments that offer better capability, efforts to apply 
27 existing technology to different materials so that \ve can 
28 get a drug test result that tells us different things. 
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2 of some of the ones that I think are of significance in 
3 the last couple of years. 
4 Some of the myths that were advanced early on 
5 about drug test results have been very authoritatively 
6 debunked in the last couple of years. 
7 As an example. you y.rill still occasionally hear 
8 the concern that melanin, vrhich is a pigment that's 
g responsible for skin color in dark-skinned individuals, 
10 can cause a false positive drug test. 
11 It's not true. And it's been authoritatively 
12 disproven. It's gone from the status of an unproven 
13 allegation to the status of a disproven allegation if 
14 you will. 
15 There has been for years a major concern that 
16 over-the·-counter medications can cause a positive drug 
17 test result with one of the emittant testing procedures 
18 that many laboratories use to do these drug tests. It's 
19 one of things you'll see most often in press ·-- in press 
20 discussions of druq testin0. 
21 In soite of the fact that these are confirmation 
22 test , which has, for a long time, made this a nonproblem 
23 and has prevented this from occurring. The manufacturer 
24 of the tests, Yosiba (phonetic) Company, has responded 
25 to the root source of the problem, and they've 
26 developed a new version of that test procedure that does 
27 not respond to over-the-counter ~edications. That's 
28 expected to be available at the laboratories by the end 
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2 uncertainty that will have been resolved. 
3 We can go on in the course of these programs, 
4 things like the fact that poppy seeds often contain enough 
5 morphine and codeine to produce a positive test result 
6 for morphine. 
7 The problem in a drug testing program, because 
8 morphine is what you see in the urine of a heroin user, 
9 you're faced with differentiating somebody who ate a poppy 
10 seed bagel from a heroin user. There's a lot of work 
11 going on in the last year to develop a new test procedure 
12 for a substance called 6-monoacetylmorphine. That's the 
13 substance you see in the urine of heroin users, but not 
14 from poppy seed ingestion. So we are improvinq our 
15 ability to differentiate those two circumstances. 
16 A technique that you'll hear a lot about in 
17 legislation and discussions of drug testing called 
18 gaschromatography/mass spectrometry, which has to this 
19 date, become the gold standard in drug testing techniques. 
20 But the manufacturers of the analytical instruments 
21 aren't stopping there. There's been a lot of work to 
22 improve upon the gold standard. 
23 There's one device now available that puts a 
24 third test on top of the GC/MS system. uses a technique 
25 called infrared spectroscopy. 
26 There's another technique being explored to 
27 put two mass spectrometers together and produce instruments 
28 that give you better and better test results and allow you 
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2 And the last example, and I think one you'll 
3 hear more detail about from your next witness, is there 
4 have been extensive studies on the use of existing 
5 technioues like i:mmunoassays and GC/f'lS to test materials 
6 other than blood or urine. And those, in some cases, can 
7 allow you to answer different sorts of questions. 
8 ~'7ork on testing for :marijuana in saliva, for 
9 instance, is aimed at being able to determine 'tlhether or 
10 not somebody's used marijuana within a few hours of the 
11 test, because it doesn't persist in that medium very long. 
12 If you conduct drug tests on hair, it's kind 
13 of the other side of that coin. You might be able to 
14 determine whether or not drug use in a given individual 
15 has been chronic for a long time or whether it's 
16 episodic. 
17 There are a lot of questions that remain to be 
18 answered about these techniques before we really under-
19 stand how useful they might be, but they do have a lot 
20 of potential and are very interesting. 
21 So , \ve could as a technical person, I could 
22 spend a lot of time in talking about -- about other --
23 other sorts of development. But these examples, I think, 
24 already illustrate the main points that I wanted to make 
25 today. 
26 The first is that technological competence 
27 and the available of technological competence really does 
28 not pose any substantial obstacle to successul drug 
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2 Technology that we have in place is already very 
3 good. To the extent that there are technical weaknesses 
4 in existing procedures, I think there's a lot of reason 
5 to believe that those \vill be addressed in very short 
6 order. 
7 So, the technical objections to proceeding with 
8 the programs are really very limited. I think it would be 
9 a major error to assume or to conclude from the fact 
10 that there are improvements on the horizon that we ought 
11 to stop and wait for those to come into play before we 
12 proceed with the testing programs. We hear that suggestion 
13 fairly often from' individuals who have a lot of concern 
14 about how these -- the effect these programs have. 
15 Drug abuse in the workplace is a problem that's 
16 not going to wait for that sort of a solution. As people 
17 earlier today have said, it's very real, it's substantial, 
18 and the testing programs that we have available to us 
19 today can make a substantial impact on that. 
20 I think the technology that is in place ought 
21 to allow us to proceed. 
22 SENATOR SEYMOUR: Thank you, Mr. Fogerson. 
23 The question I would have, do you have any 
24 information or can you speak with some authority relative 
25 to the quality of testing most recently done on Olympic 
26 athletes, or anything -- anything you might be able to 
27 share with us relative to quality of testing that is 
28 currently being used in the NFL and AFL? 
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hard to 
2 s~eak -- they're slightly different situations. The 
3 OlviT'pic testing that's received the most publicity 
4 lately has been steroid testing. 
5 And that's a little different from drug testing 
6 in a lot of respects, because the detectable problems 
7 associated with steroid analysis aren't detecting the 
8 material in the urine. They are interpreting what that 
9 means. Because in many cases, what you see in the urine 
10 from the steroid user are things you normally see in the 
11 urine from anybody, but the ratios, the amounts are 
12 wrong. So you get into very complicated issues of \•Jhether 
13 or not the ratios you see in a given individual are 
14 explicable 1n terms of their own -- their own physiology. 
15 The other problem with addressing the quality 
16 control there is that it's a very restricted, tightly 
17 controlled program. There are two laboratories, I believe, 
18 that currently are authorized to do the testing, who 
19 don't participate in any externally monitored quality 
20 control program. So, they just aren't very well measured 
21 there. 
22 The technology should be adequate, but I don't 
23 think it's been demonstrated with those particular 
24 laboratories in any publicly -- in any publicly released 
25 information that is, in fact, not a problem. 
26 NFL testing, I am not myself certain who is 
27 doing that testing now. The laboratories that I knew to be 
28 doing it a couple of years ago did, in fact, participate 
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2 think there ~ftrould be any particular problem vli th those --
3 those organizations. 
4 SENATOR SEYMOUR· Thank you very much. Appreciat~ 
5 your testimony, ~'lr. Fogerson. 
6 Our final witness is Dr. \<'Jerner Baumgartner, 
7 Scientific Director for Psychemedics Corporation. 
8 You've been with us most of the day. I admire 
9 your tenacity. 
10 DR. BAUMGARTNER· Yes, I think tenacity is the 
11 name of the game. A masochist, I don't know. 
12 (Laughter.) 
13 DR. BAUMGARTNER: Twelve vears of research. 
14 I thank you, Mr. Chairman, for letting me have 
15 the last word today. I hardly ever get this at home now, 
16 since roy children are growing up. But it helps me -- it 
17 allows me to address the issues raised by so many 
18 individuals here. 
19 I greatly appreciate this opportunity to present 
20 to you some of our experience with the new drug testing 
21 technology based on the analysis of human hair, which I 
22 believe will solve the major problems of urinalysis. 
23 I ask that my written testimony 
24 and letters from the legal and scientific community be 
25 submitted for the record. 
26 Hair analysis for drugs of abuse was invented in 
27 my VA laboratory in 1977! and it's referred to as 
28 radioimmunoassay of hair or RIAE. RIAH happens to spell 
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2 one of those little gimmicky accidents that helps 
3 sometimes. 
4 It's ir-l~Jortant to note that radioimmunoassay 
5 of hair, or RIAE should not be confused v.Ji th the 
6 nutritional hair analysis. That's a test that's quite 
7 different and it's not accepted in the medical community. 
8 RIAH is. 
g RIAE hair analysis was originally developed 
10 for addressing some of the clinical problems encountered 
11 in the treatment of drug addiction. However, this test 
12 i)rornises now to be particularly useful for legal 
13 proceedings, especially for protecting people asainst 
14 faulty urinalysis tests as well as for screening personnel 
15 in positions of high responsibility, such as those 
16 affecting public safety; that is, for positions for which 
17 there is a growing consensus that the adverse effects of 
18 drug addiction cannot be tolerated. 
19 To assure public safety, we need to test such 
20 individual critical employe~s by methods which are, one, 
21 evasion proof and, second, error free. 
22 It can be readily demonstrated that urinalysis 
23 does not meet these requirements. For one, urinalysis 
24 can be easily evaded at a preemplo:rment screening or at 
25 regularly scheduled physicals merely by the prewarned 
26 applicant abstaining from drug use for tvro or three days 
27 prior to the scheduled test~ As the }\CLlJ merrber pointe(l 
28 out, it's an IQ test. Thus, although urinalysis can be 
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2 effective, since it fails in its primary objective 1 that 
3 of gu·iranteeing the public drug- free employees in 
4 position of public safety. And, of course, it is 
5 generally recognized that urinalysis is not error free. 
6 I should, of course, mention that the marijuana 
7 test is an exception, because it does hang around in the 
8 urine for longer periods of time. 
9 Particularly worrisome are errors caused by 
10 mixed up or contaminated urine samples, or those where 
11 positive tests resulted from the ingestion of contaminated 
12 or spiked food, drinks, or poppy seeds, since such 
13 evidential, nontechnical, false positives cannot be 
14 identified by the usual GC/MS confirmation procedures. 
15 That's a very important point. 
16 And vJe have uncovered a lot of subversive 
17 activities that's going on. People can remove others 
18 from positions by engaging in either spiking of food and 
19 so on. 
20 Hair analysis, on the other hand, is essentially 
21 evasion proof and fail safe. It is evasion proof, because 
22 hair provides a permanent record of a person's drug 
23 use over long periods of time, depending on the length of 
24 hair. This can go from months to years. 
25 Since head hair grows approximately a half an 
26 inch per month, a one and a half inch long hair specimen, 
27 for example, provides a record of drug use for a period 
28 of three months. 
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2 window of detc~ction of only two to three days for r.1ost 
3 drugs, except for marijuana, as I pointed out. Thus, 
4 in the case of hair analysis, abstaining from drug use two 
5 to three days prior to a preemployment screen will not 
6 enable a druc user to evade detection. 
7 Also, hair can be collected "''i th6ut embarrassment 
8 under close supervision, one can -- and thereby avoiding 
9 evasive maneuvers against -- which work against urinalysis, 
10 such as substitution or adulteration of samples. 
11 Neither does excessive fluid intake have an 
12 effect on hair analysis. 
13 If there's a concern about the validity of a 
14 particular hair analysis result, one can always repeat the 
15 analysis ~Hi th a newly collected sample, which is identical 
16 to the first sample. This is not possible ~:lith urine. 
17 Also, other ~roblems, such as poppy seed ingestion and 
18 specimen contamination do not affect hair analysisi thus, 
19 hair analysis is essentially fail safe. 
20 One of the most important immediate applications 
21 of hair analysis, therefore, is as a confirmation test for 
22 disputed urinalysis results. By thus acting as a safety 
23 net, the strained relationships between employers and 
24 employees due to the fear of erroneous test results can 
25 be greatly reduced. I think this is one of the big issues 
26 raised by the union and others. 
27 rJhile it is easily demonstrated that hair 
28 analysis, at a price of approximately $15 per substance 
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1 analyzed, is cost-effective for screening employees ln 
2 public safety positions, such. costs may not be 
3 justifiable in the case of v1ide scale drug screening of 
4 noncritical employees. 
5 Of course, there are the legal and ethical 
6 objections to such wide-scale testing. 
7 The preemployment testing situation, of course, 
8 on the other hand, is based on different types of issues 
9 and, of course, hair analysis could probably be applied 
10 there 'i\7ithout too many difficulties with the ACLU I hope. 
11 Another major technical advantage of hair 
12 analysis is that it provides a quantitative measure of 
13 a person's drug use. That is, we can distinguish between 
14 heavy, medium, and light use and, of course, no use. 
15 In contrast to this, urinalysis can only 
16 demonstrate what drugs, but not how much vms used. Hair 
17 analysis in a medical setting can therefore tell us whether 
18 a patient is improving, staying the same, or getting 
19 worse. 
20 Hair analysis promises, therefore, to have a majo 
21 impact on drug rehabilitation programs where objective 
22 evaluation of treatment outcome is a long overdue event. 
23 As a final point on the difference between hair 
24 analysis and urinalysis, I would like to indicate that my 
25 statement should not be construed to be an attack on 
26 urinalysis. Actually, the two tests are complementary. 
27 Urinalysis is best suited for short-term 
28 monitoring; that is, two to three days after possible drug-r 
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2 retrospective hair analysis for the screening of critical 
3 personnel and, of course, for clinical evaluations. 
4 Hair analysis has been extensively field tested 
5 by us through numerous analyses in over 2,000 human 
6 subjects and has been confirmed by 23 independent 
7 scientific studies, including those by the FBI and Naval 
8 Research Laboratory. 
9 Our studies were performed with patients at the 
10 Il\.etro;;olitan State Hospital in Non,Talk, where we 
11 demonstrated by hair analysis that 19 percent of 
12 admissions had prior PCP exposure; thereby, assisting 
13 greatly in the diagnosis of PCP-induced toxic psychosis. 
14 Urinalysis testing by an independent laboratory 
15 at a detection level of one nanogram per mil failed to 
16 detect any of these cases. The reason being that these 
17 cases --· the psychotic patients had, of course, chronic 
18 use and not recent use. 
19 So, thus, hair analysis holds considerable 
20 promise for discriminating between drug-induced psychosis 
21 and schizophrenic psychosis; the latter requiring 
22 frequently 10 times of financial outlay for treatment than 
23 the former. 
24 Other studies were performed with rehabilitation 
25 centers at Long Beach, the \··Jest Los Angeles VA Hospital, 
26 and the Navy in f-an Diego. In these studies, hair analysis 
27 was used for diagnosing the severity of drug use, 
28 monitoring progress of treatment, and evaluating treatment 
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1 outcome and recidivis~. 
2 Hair analysis in these settings promises to be 
3 useful for utilization revie''"' companies and employers 
4 for referring patients to appropriate cost-effective 
5 treatment programs; for example, outpatient versus inpatien~ 
6 programs. It has been estimated that approximately 10 
7 percent pregnancies; that is, about 400FOOO babies per 
8 year have some sort of drug involvement. 
9 And I know you had a hearing this morning. I'm 
10 sorry that I didn't know about it, I would have been 
11 there. Very interesting and a very severe problem. 
12 The long-term medical consequences of such 
13 exposure and consequently the financial consequences to 
14 the nation are still largely unknown. Prenatal drug 
15 exposure has become a major focal point of medical 
16 research, one in which hair analysis has been shown to 
17 play a pivotal role. Our ability to go back in time to 
18 establish the severity of drug exposure in the first, 
19 second, and third trimester and our superior detection 
20 efficiency of prenatal drug abuse has been recognized as 
21 an important breakthrough by leading researchers in the 
22 field. 
23 1;•7e have successfully completed preliminary field 
24 studies in the last couple of months and are currently 
25 looking for financial support, as usual, for major studies 
26 in this area. 
27 Finally, vre have just completed a $200,000 
28 field studv funded by the National Institute of Justice 
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2 po2ulations. They found that hair analysis detected 
3 over 300 percent more drug--related violations than random 
4 urine testing, the latter performed at a rate of six times 
5 per month in one of the toughest jurisdictions the 
6 Santa Ana/Los Angeles Probation/parole district, which was 
7 a real surprise to us and also a bit of a shock to the 
8 b)robation department 
9 These studies suggest that h~ir analysis will 
10 be of even greater utility in evaluating the risk to 
11 society from arrestees at the pretrial stage~ that is, in 
12 situations \vhere no urinalysis data is available, but 
13 where hair analysis can provide an accurate quantitative 
14 long-term overview of an arrestee's previous drug use. 
15 We, at Psychemedics, along with physicians and 
16 law enforcement agencies and personnel managers are 
17 excited by the prospects of addressing our nation's 
18 drus problems through hair analysis. 
19 Thank you very much for the opportunity of 
20 presenting our experience to you. 
21 SFNA'I'OR SEYJ'10UR: Thank you, Dr. Baumgartner. 
22 I1ay I ask a couple of questions? 
23 One, is there any possibility of a false 
24 negative or false positive testing with hair analysis? 
25 DR. BAUHGA.ET:tJER ~ The false negatives are 
26 extremely low. One of the problems of false negatives or 
27 the definitions of false negatives,when you come to 
28 urinalysis, is that it doesn't address the population. 
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1 You see, what they are saying is that we have 
2 ~ENATOR SEYMOUR: I referred the question to 
3 hair analysis. 
4 DR. BAUMGARTNER: Yes. I just want to compare 
5 this. 
6 SENATOR SEYHOUR: Okav. 
7 DR. BAUMGARTNER: You see, with urinalysis, 
8 if you have 10 positive urines and you miss five, you call 
9 these fives false negatives. But what you're not 
10 addressing is -- and this is a critical issue -- is that 
11 many people, by abstaining prior to a preemployment test, 
12 are really false negatives. They only stopped two days 
13 of use. You see? 
14 So, in our situation, we have essentially no 
15 false negatives, but false negatives defined in the 
16 realistic sensei namely, guaranteeing the public drug-free 
17 employees in high security positions. 
18 The urine test cannot guarantee this. And, as 
19 a matter of fact, one of the --
20 SENATOR SEYHOUR: Again, I':n not interested in 
21 urine tests. 
22 DR. BAUMGARTNER: Right, but you see the 
23 difference. 
24 SEN~_ TOR SEYNOUR ~ Right. 
25 DR. BAU!1GARTNER: There are no significant false 
26 negatives compared to urine. And that is an important 
27 issue. 
28 SENATOR SEYMOUR: And regarding to compared to, 
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2 DR. BAUMGARTNER: Right. 
3 SENATOR SEY',OUR: Fair analysis only. 
4 DR. BAm1GAR.TNER: Right. 
5 SENATOR SEY!·10UR: I'm trying to look for the 
6 hishest quality test --
7 DR. BAUMGARTNER~ Right. 
8 fFNATOR SEY~t10UR: that can be found. 
9 DR. BAUMGARTNER: In terms of known false 
10 negatives, we have the highest quality by far, by far. 
11 SFNATOR SEn·10UR: \·Jhat? lYhat oercent? 
12 DR. BAWilGARTNER: I would say our tests so 
13 far have picked just about close to a hundred percent 
14 have identified drug use at a hundred percent efficiency; 
15 whereas, urinalysis has failed. 
16 SENATOR SEYHOUR: I just want to focus on hair 
17 analysis. 
18 DR. BAUMGARTNER: Well, you may not be able to ---
19 SENATOR SEYMOUR: It's not a comparison. I 
20 want to know what the state of the art is. 
21 
22 SENATOR SEYMOUR: And I think w~at you're 
23 suggesting to us is that hair analysis is the state of the 
24 art --· 
25 
26 
27 
28 
DR. BAm'lGARTNER: For false --· 
SFNAT0R SEYHOUR: I'm trying to -·-
DR. BAUMGARTNER: negative. 
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1 SENATOR SEYMOUR: -- confirm it. 
2 DR. BAUMGARTNER: For not having false negatives. 
3 SENATOR SEYPIDUR: How about false positives? 
4 DR. BAUMGARTNER: False positives, we have not 
5 identified a single case in 2,000. The reasons are 
6 obvious. v.1e also use mass spectrometry confirmation. 
7 And there are other reasons why this is not a 
8 problem, but -- but the main reason always, when it comes 
9 to addressing the issue of false positives ~-
10 SENATOR SEYMOUR: Without this confirmatory 
11 DR. BAUMGARTNER: We do mass spectrometry 
12 confirmation. 
13 SENATOR SEYHOUR: Yes, but '~-'Ji thout the 
14 confirmatory testing --
15 DR. BA.UHGARTNER: 'h'ithout confirmatory 
16 mass spectrometry, we have not seen a single false 
17 positive. And the reason for that is in order for a false 
18 positive to occur through cross-reactivity, the 
19 cross-reacting substance has to be there in vastly larger 
20 concentrations than the one you're testing, such as a 
21 medication versus drug. 
22 And it turns out that in hair, you don't get 
23 these enormous variations in chemicals. If an 
24 antiinflammatory agent shows up in hair, it's there 
25 roughly in the same concentration as the drug, and then 
26 cross-reactivity in the screening test is not a problem. 
27 So -- and we've tested that. ~-Je have -- we've demonstrated 
28 
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2 But v.Je still v.Tant to do mass spectrometry. 
3 It's, you know, it's a standard, and --
4 SENATOR SEYMOUR: I think confirmatory testing 
5 of a different type is always a good idea, but I'm 
6 really trying to focus on the accuracy of hair analysis 
7 standing alone. 
8 Can hair analysis determine what different 
9 drugs may have been used for in the system when you have 
10 a situation of polydrug abuse? 
11 DR. BAUMGARTNER: Yes. 1\fe -·- I shouldn't -- I 
12 didn't mention, but we've identified PCP, heroin, 
13 marijuana, cocaine, amphetamines, methadone, you know, 
14 also --· 
15 SENATOR SEYMOUR: Suppose I was using coke and 
16 alcohol? 
17 DR. BAUMGARTNER: But we are also looking 
18 SENATOR SEYJ110UR: l'70uld hair analysis pop out 
19 a result that says, "He's using coke and alcohol"? 
20 DR. BAUMGARTNER: T'Je have not developed a hair 
21 test for alcohol at this point. But we can detect 
22 polydrug users by hair analysis. 
23 SI:NATOR SEY~"10UR: So, if I was using coke and 
24 marijuana 
25 DR. BAUMGARTNER: Yes. 
26 SENATOR SEY~10UR: -- you could. 
27 DR. BAm1C::Af\TNEF.: Right. And I can also tell 
28 vou how much. You can say, roughly, vou're using about 
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1 eight grams per vveek or, instead, you've just been at a 
2 partv and somehow you either got a spiked drink or you 
3 were coerced under the circumstances. 
4 So, that's the important thing that we can 
5 distinguish between heavy, medium, or light users. 
6 SENATOR SEYMOUR: Okay. 
7 v:ell, thank you very much, Dr. Baumgartner. 
8 I appreciate your testimony. 
9 That will conclude our hearing. I will merely 
10 say the question of whether -~ and this includes tvvo 
11 days of hearings on drug testing. 
12 I merely say, relative to the question of 
13 whether or not we will introduce some legislation in the 
14 area of drug testing, that decision has not been made. 
15 \•Je are certainly going to evaluate the testimony 
16 we've received in these last couple of days, and then talk 
17 to those people vlho have an obvious interest in this, 
18 those very people that organizationally were represented 
19 in testimony. 
20 And so, just let me say thank you to all of you 
21 who participated in the hearing and provided your 
22 testimony. 
23 We're adjourned. 
24 (Thereu?on the hearing was adjourned 
25 at 4 : 3 2 p . m. ) 
26 --oOo--
27 
28 
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3 I, Nadine J. Parks, a shorthand reporter of the 
4 State of California do hereby certi that I am a 
5 disinterested person herein; that the foreging hearing 
6 before the Senate Select Committee on Substance Abuse 
7 was reported in shorthand by me, and thereafter transcribed 
8 into typewriting. 
9 I further certify that I am not of counsel or 
10 attorney for any of the parties to said hearing, nor in 
11 any wav interested in the outcome of said hearing. 
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13 6th day of December, 1988. 
14 
15 
16 
/··~· ~ c .• . / ..... / 
·1u2. ·v~ 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
PETERS SHORTHAND REPORTING CORPORATION 
3336 BRADSHAW ROAD, SUITE 240 
